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Caspases belong to a unique class of cysteine proteases which play critical 
roles in important processes such as cell death, differentiation and inflammation. The 
central feature of caspase function resides on their ability to selectively cleave cellular 
proteins at specific recognition motifs. The caspase degradome, or the natural 
repertoire of caspase substrates, spans across a multitude of functional classes, from 
DNA binding proteins to cell-surface receptors to viral proteins. With more than 300 
substrates characterized to date and many more expected to be discovered, the 
proteome-wide identification of caspase substrates presents a refreshing direction for 
deepening our understanding of caspase biology in health and disease. In this thesis, a 
series of computational studies were conducted to meet this goal. Firstly, data on 
experimentally-verified caspase substrates was meticulously extracted from literature, 
cleaned and deposited into a web-accessible database 
(www.casbase.org/casvm/squery/index.html). Secondly, using datasets constructed 
from the database, a support vector machines (SVM) system was developed to predict 
for caspase cleavage sites on protein sequences. The SVM method was shown to be 
comparable, if not better than existing algorithms for predicting caspase cleavage 
sites. A web server, CASVM (www.casbase.org/casvm/index.html) incorporating the 
SVM method was developed for the scientific community. Thirdly, as a measure 
towards predicting caspase substrates, a two-step prediction model, incorporating the 
SVM method and structural factors (e.g. solvent accessibilities and secondary 
structures) for substrate cleavage was designed. The two-step model was shown to 
enhance prediction accuracy by reducing the proportion of false positives from 
cleavage sites prediction. Lastly, the SVM method was used to predict for potential 
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caspase substrates among the family of receptor tyrosine kinases. The results suggest 
that these receptors could be commonly regulated by caspase cleavage and implicate 

















Chapter 1: The Caspase Degradome 
1.1 Introduction 
Proteolysis is a distinctive class of mechanism for cellular control in all living 
organisms (Barrett et al., 1998). Proteases (also known as proteinases, peptidases or 
proteolytic enzymes) represent the proteolytic engines of the cell, cutting and dicing 
up cellular and extracellular proteins, though the catalysis of peptide-bond hydrolysis. 
Constituting 1.7% of human genes, proteases form the largest enzyme family with 
566 members - larger than the kinases family and second only to the transcription 
factors family in size (Puente et al., 2003). Proteases are intimately involved in the 
initiation, modulation and termination of a myriad of essential biological processes 
such as DNA replication, cell cycle control, cell proliferation, differentiation, 
migration, morphogenesis, tissue remodeling, haemostasis, immunity and apoptosis. 
Not surprisingly, aberrant protease activity has been implicated in many pathological, 
life-threatening conditions such as cancer, neurological diseases and heart 
abnormalities.  
The hallmark of a protease’s activity resides in the catalysis of specific and 
non-reversible hydrolysis of the peptide bond between two amino acids. The protease 
substrate binds specifically to the protease at a uniquely structured cleft called the 
active site. The protease active site constitutes a set of subsites which serve as specific 
binding pockets for the residues on the substrate. The specific accommodation of a 
substrate residue to each subsite ensures that only a restricted set of sequences on the 
substrate is cleaved (Figure 1-1). The catalysis of the scissile bond hydrolysis is 
mediated by a key amino acid on the protease which serves as the catalytic 
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nucleophile. Consequently, five classes of proteases have been categorized in 
accordance to the nature of the catalytic nucleophile; namely the serine, cysteine, 
threonine, metallo, or aspartyl proteases. 
While proteases were originally known for their role as digestive enzymes, 
they are increasingly being recognized as signaling molecules through specific 
substrate cleavage. Proteolysis have been shown to generate an eclectic range of 
changes in the structure and function of the target protein such as repression of the 
protein’s function through the removal of a catalytic domain, or a severance of an 
inhibitory domain leading to enhanced protein activity and even a complete 
transformation of the protein’s intended cellular role. In any case, the functional 
identity of a protease is often defined by the uniqueness and extent of its substrate 
repertoire.  For example, the matrix metalloproteinase family of proteases mediates 
tissue re-modeling, cell migration and cancer metastasis through the cleavage of 
extracellular components such as collagen (Overall and Blobel, 2007). Granzymes, a 
class of serine proteases, serve as potent initiators of apoptosis where they cleave and 
activate upstream pro-apoptotic signaling molecules (such as Bid) during cytotoxic T-
cell mediated cell death (Lord et al., 2003). 
 Figure 1-1 Schematic diagram of hypothetical protease-substrate interaction at protease active site as suggested by Schecter and Berger (1967). Substrate residues 
(P2-P1-P1’-P2’) in contact with protease active site subsites (S2-S1-S1’-S2’) respectively. 
Proteolytic cleavage (black triangle) occurs at the peptide bond (also called the scissile bond 




In recent years, a family of cysteine proteases, called caspases, has been a 
subject of great interest to researchers (Yuan et al., 2003). These proteases are found 
to cleave a bewildering array of cellular substrates, ranging from membrane structural 
components to signaling molecules to transcription factors. The selective cleavage of 
cellular proteins by these proteases implicate them as important signaling molecules 
in the initiation and execution of apoptosis, as well as in other important cellular 
processes such as inflammation and differentiation.  
In an attempt to further the understanding of caspase biology, a series of 
computational studies were initiated on the atypical repertoire of caspase substrates. 
The studies revealed a much greater level of complexity in the mechanistic regulation 
of substrate cleavage and unraveled additional modes of regulation by caspases in 
signaling pathways. However, before the discourse on these findings, a 
comprehensive review on caspase biochemistry and their substrate repertoire will be 
presented. 
 
1.2 Caspase Biology 
1.2.1 Discovery 
The term caspase is the short for cysteinyl aspartate protease. The discovery 
of caspases was dated back to 1992 when ICE (for interleukin-1β converting enzyme), 
also known as caspase-1, was identified as the protease that cleaves pro-interleukin-1β 
to its pro-inflammatory active form, establishing the involvement of ICE in mediating 
inflammation (Thornberry et al., 1992; Cerritti et al., 1992)  At about the same time, 
genetic studies on the cell death pathway in the nematode, C. elegans, identified the 
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ced-3 gene as being essential for programmed cell death in the worm during 
development (Yuan and Horvitz, 1990). Later, the cloning of the ced-3 gene by Yuan 
and co-workers led to the identification of the gene as a C. elegans homologue of the 
mammalian ICE (Yuan et al., 1993). These observations suggested a conserved 
programmed cell death mechanism involving these cysteine proteases. Subsequent 
work led to the identification of other cysteine proteases with homology to the ced-3 
gene. The sequential characterization of ced-3 homologues by various research groups 
took place without a controlled nomenclature but was eventually standardized with 
the name “caspase” in 1996 (Alnemri et al., 1996). At present, total of 12 caspases 
have been identified in mammals: caspase-1 to -10, caspase-12 and caspase-14 (Yuan 
et al., 2003; Pistritto et al., 2002). The protein initially named caspase-13 was later 
found to represent a bovine homolog of caspase-4 (Koenig et al., 2001), and caspase-
11 is most likely the murine homolog of human caspase-4 and caspase-5 (Kang et al., 
2000). 
1.2.2 Caspase Structure and Activity 
As reviewed as Nicholson (1999) and Yuan et al. (2003), the distinguishing 
trait in all members of the caspase family is the specificity for substrate cleavage after 
an Asp residue at P1, a trait which is exceptional among mammalian proteases. The 
primary specificity pockets at P1 in caspases are almost identical, being formed by the 
side chains of the strictly conserved residues, Arg-179, Arg-341 and Gln-283 
(caspase-1 numbering). This deep, highly basic pocket is perfectly shaped to 
accommodate an Asp side chain with a much lower efficiency for a Glu. In addition, 
caspases are shown to preferentially recognize and cleave at unique tetrapeptide 
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Table 1-1 Optimal tetrapeptide specificities of caspases 
 
signature motifs (P4-P3-P2-P1) on substrates. Accordingly, these proteases are grouped 
into three categories based on their optimal tetrapeptide cleavage sequences as 
characterized by Thornberry and co-workers (Thornberry et al., 1997) using in vitro 
combinatorial methods (Table 1-1). The differences between the optimal sequence 
preferences are largely attributed to the requirement of the P4 residue. Group I 
caspases (caspases-1, caspase-4 and caspase-5) share a preference for residues with 
bulky, hydrophobic side chains at the P4 substrate position (tryptophan or leucine), 
while Group II caspases (caspase-2, caspase-3 and caspase-7) prefers the negatively 
charged aspartic acid and Group III caspases (caspase-6, caspase-8, caspase-9) is 
optimized for leucine or valine. All groups, however, have an absolute preference for 
aspartic acid at P2 and a hydrophobic P3 residue. 
Besides their preference for specific cleavage site sequence motifs, caspases 
share a number of other distinctive features. The catalysis of protein cleavage is 
governed by a critical cysteine residue, which is a part of a conserved QACXG (X = 















C, G, Q or R) pentapeptide sequence motif. The caspase enyzme is synthesized as an 
inactive zymogen which contains a prodomain, a large and small subunit. Enyzme 
activation is activated upon proteolytic cleavage by other members of the caspase 
family, or by other proteases such as granzyme B. The activation process is carried 
out sequentially, firstly through cleavage and separation of the large and small 
subunits, followed by the removal of the prodomain after another cleavage event on 
the large subunit. The large subunit and small subunit then associate with each other 
to form a heterodimer which unites with another identical heterodimer, generating an 
active tetrameric caspase molecule. Each tetrameric caspase molecule contains two 
active sites, one from each heterodimer. A structural model of caspase-3 is illustrated 
















Figure 1-2 Structure of caspase-3. The structure of active caspase-3 is a tetramer 
comprising of two copies each of the p17 (large) and p12 (small) subunits from residues 
35-173 and 185-277 of each proenzyme (green and blue) respectively. The four 
polypeptide chains associate to form a compact (p17/p12)2 tetramer containing two 
active sites. The p17 and p12 subunits interact extensively with each other with the core 
of the enzyme being formed by a central 12-stranded β-sheet. Each p17/p12 dimer 
donates six strands. At the enzyme active sites, each copy of the inhibitor (Ac-DVAD-
fmk) binds in a narrow cleft across the C-terminal end of the central β-sheet. Image from 




1.2.3 Caspase Function  
Much of the current understanding of caspase function is derived from studies 
on their role in apoptotic cell death – a form of programmed cell death conserved in 
metazoans (reviewed in Hengartner, 2000). Caspases execute downstream 
biochemical changes in the apoptotic cell such as shutting down of basic survival 
processes, termination of growth signals and dismantling cell architecture. Caspases 
are activated via two pathways in apoptosis: intrinsic and extrinsic (Figure 1-3). The 
extrinsic pathway is initiated when the CD95 ligand binds to the CD95 death receptor, 
leading to receptor oligomerization and the formation of the death inducing signaling 
complex. The multi-protein complex recruits, via adaptor protein FADD, multiple 
pro-caspase-8 molecules, leading to the cleavage and activation of the enzymes 
through an induced proximity mechanism. Upon activation, caspase-8 functions as an 
initiator caspase as it cleaves and activates downstream pro-caspase-3. Active 
caspase-3 serves as an executioner caspase by cleaving a myriad of downstream 
cellular proteins, generating the phenotypic changes observed in the apoptotic cell.  
In contrast, the intrinsic pathway is initiated when cellular perturbations such 
as genotoxic stress or internal insult propagate downstream pro-apoptotic signals that 
converge at the mitochondria. Pro-apoptotic and anti-apoptotic members of the Bcl-2 
family of apoptotic regulators meet at the surface of mitochondria, where they 
compete to regulate the release of the pro-apoptotic molecule such as cytochrome c 
and Smac.  When the balance is tipped in favor of the pro-apoptotic Bcl-2 regulators, 
the mitochondria permeability becomes compromised, leading to the release of the 
pro-apoptotic molecules. Cytochrome c, upon release into the cytoplasm, associates 
with Apaf-1, pro-caspase-9 and other molecules to form a heptametrical protein 
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complex called the apoptosome. Within this multi-protein complex, pro-caspase-9 is 
activated and goes on to cleave and activate downstream pro-caspase-3 molecules. 
Both extrinsic and intrinsic pathways converge at the level of caspase-3 activation. 
Caspase-3 activation and activity is antagonized by the IAP molecules, which 
themselves are antagonized by the Smac protein released from mitochondria. Notably, 
cross-talk and integration between the extrinsic and intrinsic pathways is mediated by 
Bid, a pro-apoptotic Bcl-2 family member. Active caspase-8 cleaves Bid during 
extrinsic apoptotic signaling which translocates to the mitochondria, abrogates the 
activity of anti-apoptotic Bcl-2 proteins and mediates cytochrome c exit. Also, 
positive feedback regulation is mediated through caspase-3 cleavage of upstream 
initiator caspases; caspase-8 and caspase-9. 
Interestingly, while most caspases are involved in apoptosis, either as 
initiator or executioner caspases, emerging evidence has implicated them in a 
plethora of other vital non-apoptotic processes (Table 1-2), suggesting a more 
disparate and complex role of these enzymes in the cell (Launay et al., 2005; Siegel, 
2006). Caspase-1, caspase-5 and caspase-11 are thought to be inflammatory caspases 
as they are primarily involved in the processing of the inflammatory cytokines. 
Remarkably, key apoptotic caspases such as caspase-3, caspase-6 and caspase-8 
have been shown also to mediate immune cell proliferation in addition to apoptotic 
cell death. Many inflammatory or apoptotic caspases were also shown to mediate 
differentiation of a wide variety of cell types such as erythroblasts, macrophages, 
lens epithelial cells, osteoblasts and keratinocytes. 
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Figure 1-3 Two major pathways in apoptosis: intrinsic and extrinsic. 
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Table 1-2 Functional roles of caspases in biological processes 




Induced apoptosis when over-
expressed. 
 
Cleaves and activates pro- IL-1 and 
pro-IL-18 
 
Component of inflammasome.  
 
Differentiation of skeletal muscle 
 
Cell migration 
Caspase-2 Initiator of extrinsic pathway or 
executioner caspase 
Differentiation of erythroblasts, 
osteoblasts and macrophages 
 
Involved in DNA repair 
Caspase-3 Executioner caspase Differentiation of erythroblasts, 
keratinocytes, macrophages, lens 
epithelial cells, sperm, skeletal 
muscle, osteoblasts and placental 
trophoblasts. 
 







Caspase-4 Might be involved in ER-
stressed apoptosis 
Might be involved in bacteria-
induced cell death 
Caspase-5 NA IL-1 production, component of 
inflammasome that activates 
caspase-1 
Caspase-6 Executioner caspase Differentiation of lens epithelial cells. 
 
























Initiator caspase of extrinsic 
pathway 
 
T cell proliferation and activation 
 
Positive cell cycle control in B cells 
 




Internalization of death receptors 
 
Caspase-9 Initiator caspase of intrinsic 
pathway 
NA 
Caspase-10 Initiator caspase of extrinsic 
pathway 
NA 
Caspase-11 Initiator caspase of extrinsic 
pathway 
IL-1 production 




Involved in innate immune response 
Caspase-14 NA Differentiation of keratinocytes 
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1.2.4 Caspase Substrates 
In 1998, the first list of caspase substrates was compiled in Earnshaw et al. 
Most of the substrates known at that time (from a total of 65) could be categorized 
into only a few functional groups, such as structural or scaffolding proteins in the 
cytoplasm and in the nucleus, signal transduction proteins, transcription factors, cell 
cycle controlling components and proteins involved in DNA replication and repair. 
More recently, Fischer et al. (2003) updated the compilation to more than 280, with 
proteins belonging to an even greater range of functional groups (Figure 1-4). Not 
surprising, transcription factors, DNA cleavage and repair proteins, RNA-associated 
proteins and proteins involved in cytoskeletal structures represented a large proportion 
of the characterized substrates. Notably, a much greater proportion of signal 
transduction proteins – such as protein kinases, G-protein signaling components and 
membrane receptors – were mentioned in the update.  
The growing list of substrates from vastly different functional groups suggests 
a much varied range of consequences of substrate cleavage as well as a more complex 
role of caspases in biological processes beyond apoptosis. However, caspase cleavage 
remains a highly selective process where target proteins are cleaved at specific 
recognition sites and purposeful changes in protein function are effected. As described 
in the excellent review on caspase substrates by Fischer et al. (2003), most outcomes 
of caspase cleavage are implicated in apoptosis and are broadly classified into two 
distinct categories: gain or loss of function of protein. The following sections 
summarize the salient points mentioned in the review. 
 
   




1.2.4.1 Gain of Function 
In many cases of caspase cleavage, the cleaved substrate exhibits an increased 
level of activity - often through the removal of regulatory or inhibitory domains - 
leading to the downstream enhancement or propagation of the apoptotic process. The 
most striking example for caspase-mediated gain of protein function is that of the 
caspase itself. As mentioned earlier, caspase cleavage of executioner caspases - 
caspases-3 and caspase-7 - by upstream initiator caspases such as caspase-9 and 
caspase-8 is required for complete enzyme activation. Several members of the PKC 
and MAP kinase pathway kinase, such as PAK2 and ROCK-1, were shown to be 
constitutively activated upon separation of the N-terminal regulatory and the C-
terminal catalytic domains through caspase cleavage. Activation of PAK2 and 
ROCK-1 is important for the expression of the apoptotic phenotype such as 
cytoskeletal reorganization and plasma membrane blebbing. Cleavage of several MST 
kinases by caspase-3 also yields constitutively active molecules which are potent 
inducers of apoptosis. 
Interestingly, caspase cleavage of certain proteins also led to the exposure of 
previously hidden pro-apoptotic domains on the native protein, converting these 
proteins into cell death effectors. Caspase cleavage of MEKK1 leads to the exposure 
of a kinase fragment which induces downstream caspase activation, causing a positive 
feedback loop for apoptosis.  Bid, a BH3 domain only member of the Bcl-2 family of 
apoptotic regulators, is cleaved by caspase-8 and translocates to the mitochondria, 
inducing cytochrome c release. The cleavage of Bid exposes a previously occluded 
hydrophobic binding surface of its BH3 motif which is important for antagonizing the 
anti-apoptotic Bcl-2 regulators. Similarly, its pro-apoptotic cousin, BimEL, another 
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BH3-domain only protein, was found to demonstrate a higher affinity for Bcl-2 and a 
markedly enhanced apoptotic activity after cleavage of its N-terminal region.  
 
1.2.4.2 Loss of Function 
On the flip side, caspase cleavage results in the loss of native protein function. 
Not surprisingly, many proteins belonging to this category belong to the scaffold and 
structural proteins of the cell– cleavage of these proteins is instrumental for the 
observed apoptotic phenotype such as nuclear fragmentation, cell shrinkage and 
membrane blebbing. For example, the DNase inhibitor, ICAD is cleaved by caspases, 
liberating active CAD nuclease that mediates DNA fragmentation. Poly-(ADP-ribose) 
polymerase or PARP, is an abundant nuclear protein that catalyses poly-(ADP-ribose) 
ligation to acceptor proteins, including itself, in response to DNA strand breaks. 
PARP cleavage by caspases-3 and caspase-7 bisects a bipartite nuclear localization 
signal, generating a form of the protein that cannot synthesize ADP-ribose polymers 
in response to damaged DNA. Caspases also terminates several proteins involved in 
maintenance of the cytoskeletal architecture such as the intermediate filaments 
cytokeratin-18 and vimentin. Cleavage of golgin-160 and GRASP65 was suggested to 
cause disassembly of the Golgi complex, and proteolysis of Bap31 disrupts the 
transport between the endoplasmic reticulum and the Golgi complex. Caspase 
cleavage of acinus and helicard was found to contribute to chromatin condensation 
and nuclear remodeling respectively. 
Proteins directly involved in anti-apoptotic signaling pathways were found to 
be cleaved and inactivated as well. The inhibitors of caspase activity, c-FLIP and c-
IAP, are inactivated after caspase cleavage. The cleaved fragment of c-IAP is pro-
17 
 
apoptotic and leads to downstream amplification of apoptosis. Cleavage of the anti-
apoptotic regulators of the Bcl-2 family, Bcl-2 and Bcl-xl results in the removal of the 
N-terminal BH4 domains which not only leads to a loss of their anti-apoptotic 
function, but also converts them to pro-apoptotic proteins. 
Signaling proteins involved in anti-apoptotic pathways, such as kinases and 
transcription factors, are inactivated through caspase cleavage during apoptosis. In 
their native state, Akt and Raf - components of survival pathways in the cell - 
inactivate pro-apoptotic molecules such as Bad. Caspase cleavage inactivates these 
molecules and contributes to a positive feedback loop in apoptosis. Anti-apoptotic 
transcription factors such as NF-κB were shown to mediate positive feedback loops 
through proteolytic cleavage. The cleavage of the p65 subunit of NF-κB generates a 
protein that is still able to bind to DNA but lack trans-activating activity, therefore 
repressing the transcription of downstream regulators by functioning as a dominant 
negative inhibitor. Also, the NF-κB inhibitor, IκB is converted to a constitutive 
protein that is no longer degraded by the proteosome upon cleavage of its N-terminal 
by caspases. 
 
1.2.4.3 Non-apoptotic consequences of caspase cleavage 
While the majority of proteins cleaved by caspases involve modulation of 
apoptotic signaling and/or changes in cellular integrity, the involvement of caspases in 
non-apoptotic processes suggest that a notable proportion of substrates not directly 
implicated in apoptosis are important as well. Several negative regulators of the cell 
cycle are cleaved by caspases, leading to their inactivation. Wee1 is a critical 
component of the G2/M cell cycle checkpoint machinery and mediates cell cycle 
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arrest by phosphorylation of Cdc2. Caspase cleavage of Wee1 in proliferating cells 
was shown to inactivate the protein, leading to cell cycle progression. Inflammatory 
cytokines such as pro-interleukin-1-beta, pro-interleukin-16 and pro-interleukin-18 
are converted into their active state via caspase cleavage. More significantly, caspases 
are also found to be involved in the propagation of neurodegenerative diseases such as 
Huntington’s and Alzheimer’s. In Huntington’s disease, caspase cleavage of 
Huntingtin abrogates its native protective function and generates a toxic N-terminal 
byproduct that sensitizes neurons to further stressors such as excitotoxic stimulation. 
Caspases are implicated in the progression of Alzheimer’s disease through the 
proteolysis of the trans-membrane APP protein at its cytosolic tail which releases the 
neurotoxic fragment, C31.  
 
1.3 The Caspase Degradome 
1.3.1 Emerging perspectives 
In a similar fashion to the genome and the proteome, López and Overall 
(2000) coined the termed "degradome" to represent the complete set of proteases that 
are expressed at a specific time by a cell, tissue or organism. The natural substrate 
repertoire of an enzyme in a cell, tissue or organism is termed as the protease 
degradome. Elucidating the degradome will help assign proteases to biological 
pathways and delineate the protease’s physiological and pathological roles (Overall 
and Blobel, 2007). Furthermore, as protease degradomes are connected with another 
through promiscuous partnerships of the same substrate to multiple upstream 
proteases, characterization of individual protease degradomes will further clarify the 
roles and significance of each protease and their downstream proteolytic events at the 
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systems level. Undoubtedly, the knowledge of protease degradomes will be useful for 
therapeutic research and drug discovery. Despite their potential, however, the protease 
degradomes of all proteases remain to be fully elucidated. To be sure, for many 
recently discovered proteases and even for many established proteases, no native 
substrates are known. Evidently, one of the most important tasks today in protease 
biology is defining the protease degradome. 
The bewildering array of caspase substrates has brought several major 
questions into focus. For instance, what is the minimal set of proteins that must be 
cleaved in order to induce the phenotypic hallmarks of apoptosis? Are there bystander 
proteins which get inadvertently cleaved alongside the mandatory set of apoptotic 
substrates? If so, just how extensive is the “collateral damage”? In addition, the 
extensive array of native substrates begs the question on how caspase substrate 
cleavage is differentially coordinated in apoptosis and presumably unrelated events 
such as cell proliferation and differentiation. In any case, it is highly likely that the 
cleavage of caspase substrates is a tightly regulated event – only selected proteins are 
cleaved under particular cellular conditions – and the dysregulation of caspase 
substrate cleavage is expected to contribute to abnormal physiology and the 
progression of human diseases.  
To date, many more caspase substrates are expected to be discovered and the 
functional consequences of several cleaved substrates remain uncharacterized. 
Accordingly, efforts to elucidate the caspase degradome will offer an alternative 
perspective for unraveling the complexities of regulating caspase substrate cleavage 




1.3.2  Methodology challenges 
Several classes of experimental methods are available to characterize protease 
substrates (López and Overall, 2000). The characterization of protease substrates has 
traditionally involved serial biochemical processes in which putative protein 
substrates, either purified from cell extracts or in-vitro translated, are incubated with 
proteases and analyzed for cleavage. Newer approaches involving genetics-based 
techniques and high-throughput proteomic tools have also been used extensively for 
substrate identification in recent times. In the former, proteins are analyzed for 
cleavage using specific gene-disrupted animal models. For example, a mutated 
substrate gene – expressing non-cleavable cleavage sites – can be used for detecting 
protease activity by observing the functional differences between the knock-out 
animals and controls. In other genetic-based methods, experiments could involve 
utilizing the yeast-two-hybrid method where the ancillary exosite domains of 
proteases can be used as baits to screen cDNA libraries for interacting proteins – the 
observation of a binding partner could represent a potential protease substrate. 
More significantly, degradomics – or the application of proteomic approaches 
for the direct investigation of proteases and proteolytic processing in a system-wide 
context – has greatly advanced the field of substrate identification. In the majority of 
degradomics experiments, large protein sets treated with or without the protease, are 
separated by gel-based or liquid chromatography approaches, and individual proteins 
are identified by tandem mass spectrometry of tryptic peptides. Many studies use cell 
lysates or cell-conditioned medium as large substrate libraries for exogenously 
applied proteases, whereas other more ambitious approaches use cell-based systems 
involving protease deficient or protease over-expressing cells. Coupled with 
21 
 
successive validation of substrate candidates by applying an array of complementary 
techniques, new protease substrates are being uncovered in a high-throughput manner. 
 The quintessential substrate detection tool will be capable of detecting 
proteolytic cleavage products of natural substrates in their biological context such as 
in cell-based systems and in tissue samples. While much progress has been made in 
advancing techniques for experimental identification of substrates, individual 
limitations in the methods suggest that no one method will lead to the discovery of all 
substrates in the protease degradome. To this end, it would be perceptive that future 
work be focused not only on improving existing methods but also on the development 
of complementary approaches. 
Over the past decade, the deluge of “omics” data in biology has rendered the 
creation of a whole generation of predictive computational algorithms and tools to 
assist research in many subject domains in molecular and cell biology, ranging from 
the detection of transcription factor binding sites to prediction of protein-protein 
interactions to the identification of signal peptide cleavage sites (Brazas et al., 2008). 
It is not surprising that computational methods for predicting protease substrates will 
serve as useful complements to experimental methods which can be cumbersome and 
time consuming. As part of the protease biologist’s arsenal of research tools, such 
computational approaches will help accelerate hypothesis generation and narrow the 
scope of experimentation. Notably, as studies clarify the mechanisms and regulation 
of caspase substrate cleavage and with mounting data on caspase substrates, it is 
plausible that reliable tools for the computational prediction of caspase substrates can 




1.4 Thesis Objectives 
The content of this thesis is centered on two primary objectives:  
1.  Elucidate the caspase degradome by identifying known and hitherto 
undiscovered caspase substrates. 
2.  Explore the application of predictive computational methods for the 
above purpose. 
The following summarizes the studies described in each chapter: 
In Chapter 2, the problems related to data for the computational prediction of 
caspase substrates was discussed. Data on caspase substrates was retrieved from 
literature and a database was developed to store and manage the data. 
In Chapter 3, a novel approach to predict for caspase cleavage sites was 
developed using the Support Vector Machines (SVM) algorithm. It was trained and 
tested with experimental data from Chapter 1 and was shown to perform better than 
existing tools.  A web server for predicting caspase cleavage sites using the developed 
algorithm was constructed. 
In Chapter 4, a multi-factor model comprising of the SVM algorithm for 
cleavage site prediction and quantitative measures of substrate structural properties 
was developed to improve accuracy of caspase substrate prediction. 
In Chapter 5, the receptor tyrosine kinase family (RTK), an important class of 
survival and growth signaling molecules, was predicted for potential caspase 
substrates. Prediction results suggest a novel mechanism of RTK regulation by 
caspases and implications in apoptosis. 
In Chapter 6, the thesis concludes with a summary of the previous studies and 
discusses these implications in the context of predicting the caspase degradome. 
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Chapter 2: Data 
2.1 The Data Challenge 
 Data integrity is of paramount importance to the entire cycle of research and 
development of computational prediction systems. Intuitively, the use of data for 
computational prediction underscores two challenges: quality and quantity. As the 
adage goes ‘garbage in, garbage out’, non-precise and inaccurate data may lead to 
spurious conclusions, while insufficient data will undermine statistical significance of 
predictive patterns, leading to less robust models. Accordingly, most computational 
prediction tools for biological problems have been developed using expertly curated 
data found in public or proprietary databases. For example, MHC-BPS (Cui et al., 
2006) and POPI (Tung and Ho, 2007), which predict for MHC binding peptides using 
protein sequences, rely on curated datasets of MHC binding peptide sequences 
derived from databases such as MHCBN (Bhasin et al., 2003), MHCPEP (Brusic et 
al., 1997) and SYFPEITHI (Rammensee et al., 1999). Similarly, signal peptide 
prediction tools such as SignalP (Bendtsen et al., 2004) and Signal-3L (Shen and 
Chou, 2007) utilizes data on signal sequences deposited in Uniprot (The Uniprot 
Consortium, 2008). 
To develop prediction tools for caspase substrates, it is obligatory for analyses 
to be carried on data on experimentally verified caspase-cleaved proteins. However, 
unlike the prediction tools mentioned earlier, there are no specialist resources or 
references where sufficient quantity of the required data can be extracted for use in 
this case. All existing tools for prediction of caspase substrates such as PeptideCutter 
(Gasteiger et al., 2005), GraBCas (Backes et al., 2005) and CasPredictor (Garay-
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Malpartida et al., 2005) are based on in vitro cleavage site tetrapeptide specificities 
reported previously by Thornberry and co-workers (1997) and not data from 
legitimate caspase-cleaved substrates. While in vitro data is undoubtedly an important 
component for analysis of caspase substrate cleavage, it is not sufficient for creating 
robust prediction models. Factors affecting substrate cleavage such as the adequate 
exposure of the cleavage site region to protease, presence of exosites on substrate or 
other post-translational regulation need to be accounted for in the prediction model as 
well – the failure to do so will greatly mitigate prediction accuracy (this subject will 
be discussed further in Chapter 4 and Chapter 6). Moreover, inadequate data were 
used for testing the validity of these tools as well. For the dataset of 280 cleavage site 
sequences used in the development of CasPredictor, no description on data retrieval or 
data cleaning was reported and the final dataset was unavailable for download on the 
website. The bio-basis function neural network-based prediction algorithm by Yang 
was created based on a limited dataset of 18 cleavage site sequences which was not 
also reported (Yang, 2005). In addition, caspase sequences in general protein 
databases such as Uniprot and GenBank (Benson et al., 2008), despite being well 
annotated with post-translational modifications such as signal sequences and 
phosphorylation sites are yet to be supplemented with data on their natural substrate 
repertoire or preferred substrate cleavage sequences. 
Evidently, the absence of reliable sources of high quality data on 
experimentally-defined caspase substrates is likely to limit the development of 
predictive algorithms and tools. This suggests that a concerted effort to extract 
relevant data from literature and making it easily accessible for researchers would be 
helpful. In this chapter, a two-step approach was carried to address these issues 
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(Figure 2-1). Firstly, a systematic process was carried to retrieve, clean and construct 
datasets for data analysis and algorithm construction from experimentally verified 
caspase substrates reported in literature. Secondly, a web-accessible relational 
database was developed to store and manage the datasets. The database was 
supplemented with tools for efficient data retrieval and knowledge discovery in 
accordance to data warehousing principles,  
 
2.2 Data Retrieval 
2.2.1 Literature Search 
The absence of a definitive source of caspase substrates data necessitates a 
thorough search for bona fide caspase substrates. Much of the currently known 
caspase substrate repertoire has been comprehensively reviewed by Fischer et al. 
(2003) and, to a lesser extent, in Earnshaw et al. (1999). As caspase substrates 
discussed in earlier reviews were included in Fischer et al., it is assumed that the latter 
had a reasonably extensive coverage of reported substrates up till the time of its 
publication in 2003. However, it is likely that many more substrates would have been 
discovered and reported in original research papers since then. Therefore, the 
currently known caspase substrate repertoire would constitute entries compiled in 
Fischer et al.  (henceforth termed as Fischer dataset) as well as those separately 
reported in original papers thereafter (or Post-Fischer dataset). 
To construct the Post-Fischer dataset, a comprehensive search on journal 
articles indexed in PubMed was carried using several permutations of keywords 
related to caspase-mediated substrate cleavage (e.g. “SUBSTRATES”, 
“CLEAVAGE”, “CASPASES”) during the period from 1 Jan 2002 through 31 May 
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2008. The keyword searches were restricted to the title of publications since a more 
inclusive search category (e.g. searches on abstracts or the entire paper) would be 
overly time consuming. While it is probable that some relevant journal articles would 
be filtered out due to the absence of the targeted keywords, such instances are not 
expected to greatly affect the final dataset. The stated start date was selected to extract 
journal articles which overlapped with those compiled in the Fischer dataset to ensure 
that all recently reported substrates were covered. To ensure that only experimentally 
-verified caspase substrates are selected, all caspase substrates suggested by authors 
were shown to be cleaved under experimental conditions (e.g. using either serial 
approaches such as in vitro protease-substrate cleavage assays or through proteomic 
methods). Substrates implied by authors with no direct supporting experiments for 
caspase cleavage were eliminated. The data retrieval process extracted a total of 53 
caspase substrates for the Post-Fischer dataset. For the Fischer dataset, 260 caspase 
substrates reported in Fischer et al. were extracted. 
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Figure 2-1 Schematic diagram depicting the processes and output involved in data 




2.2.2 Data Extraction and Cleaning 
The amino acid sequences and location of experimentally-verified cleavage 
sites on substrates were extracted from literature. Cleavage sites implied or suggested 
by authors with no supporting experiments were noted as “putative”. Also, the protein 
sequences of substrates were obtained from Uniprot databases (Swiss-Prot and 
TREMBL) through keyword searches. All substrates data were checked for 
ambiguities, typos, and other forms of errors through cross-referencing with the 
original literature and online databases. For example, the α-tubulin protein was 
erroneously reported as a caspase substrate in Fischer et al. with an unknown cleavage 
site. The cleavage site was updated to LEKD431 when cross-referenced with the 
original reporting paper. In another example, the cleavage site location of DCC 
protein was reported at Asp794 in Fischer et al., but was corrected to Asp1290 after a 
confirmation with the original reporting paper. 
The final datasets of caspase substrates are listed in Appendix A (Table A-1 
and Table A-2). 
 
2.3 Data Storage and Management 
2.3.1 The Biological Data Warehouse 
One of the most pertinent changes in biological research in the past decade is the 
burgeoning usage of databases for biological data (Galperin, 2008). The deluge of 
data from “omics”-based research - a result of the ubiquitous advances in high 
throughput technology - presents unique challenges in data storage and management. 
These challenges motivate the need to create robust and scalable database 
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architectures for data storage as well as to develop integrative workflows and tools for 
data management. 
The issue of data storage has been tackled by the collaborative efforts of 
primary databases such as GenBank (Benson et al., 2008), DDBJ (Tateno et al., 2002) 
and EMBL-Bank (Kulikova at el., 2006). These databases serve as general one-stop 
shops for the deposition and retrieval of biological sequence data and annotations. 
While these repositories excel at data storage, the very nature of their size and 
architecture presents limited usage of these tools as knowledge platforms for 
biological research of a specific field. Large databases necessarily present a 
cumbersome and tedious process of retrieval of specific datasets where redundancies 
and errors are commonplace. Also meta-data for specific biological domains, while 
important for research, cannot be conveniently integrated or retrieved within these 
databases. 
One answer to these constraints may reside on the use of boutique biological 
databases or data-warehouses (Schönbach, 2000). A biological data warehouse is a 
subject-oriented, expert collection of biological data designed for supporting 
biological data analysis and knowledge discovery. In contrast with a general-purpose 
database (such as GenBank), the biological data warehouse appears to suit the needs 
of niche research. While the general purpose databases focus on expansion and 
dissemination of information and provide basic annotation, specialized biological data 
warehouses integrates relevant information from these underlying data sources and 
merges them with expert curation and annotation. It is not surprising that an 
increasing number of specialized biological databases are being developed for a 
plethora of research domains - a collection which totals more than a thousand to date, 
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as reported in the 2008 Nucleic Acid Research Database Issue (Galperin, 2008). 
These databases address the data challenges of subject fields ranging from animal 
model genomes to cell proteomes to human diseases.  Clearly, in the biologist’s 
arsenal of research tools, biological data-warehouses are fast becoming an 
indispensable addition to the wet laboratory. 
            
2.3.2 The Caspase Substrates Database 
To address the challenges of storing and managing data, the Caspase 
Substrates Database was developed. Based on the conceptual framework of the data 
warehouse, it aims to be a central resource for expertly curated data on caspase 
substrates with tools for data retrieval and knowledge discovery. The Caspase 
Substrates Database is deployed using the MySQL database system 
(www.mysql.com) which is based on the architecture of the relational databases 
introduced by E.F. Codd (1970). In a relational database model, data is stored in a 
collection of inter-related tables - consisting of sets of rows and columns - each 
assigned to specific categories of data. The relational structure facilitates the 
extraction of multi-dimensional datasets with user-defined queries and enables 
efficient expert curation of data. Each database entry in the Caspase Substrates 
Database describes an experimentally verified caspase substrate, with annotations on 
sequence, structure and function made available through direct database links to 
Uniprot and PubMed, as well as indirect links to other useful public databases via 
Uniprot (See Databases Interconnectivity Chart in Figure 2-2). The database is hosted 




As shown in Figure 2-3, the primary interface to the database is a web form 
where users can query and retrieve data using one of three options. Database entries 
can be queried using the substrate’s database accession ID (also termed as the 
CASVM Accession ID), or using the substrate’s Uniprot Accession ID. Users can also 
execute queries through the input the keywords of protein or gene names of 
prospective substrates. Alternatively, users can submit a protein sequence to an 
integrated BLASTP search tool (Altschul et al., 1990) and retrieve a list of 
structurally similar sequences from the database. Once a query has been made, a list 
of results will be presented with corresponding links to a page containing details on 
the entry. Every database entry is annotated with the following fields on the details 
page (a screenshot is shown in Figure 2-4): 
CASVM Accession ID: The unique identifier for all substrates in the 
database. 
Substrate Name: The name of the caspase substrate in the database entry. 
Each substrate’s name is checked for consistency by cross-referencing with the 
Uniprot protein name and gene name fields. In ambiguous cases, the name as 
mentioned in literature is selected instead. 
Organism Type: The organism(s) from which the substrate was found to be 
cleaved in. Recent work have suggested that cleavage of certain caspase substrates 
were not consistent across organisms - orthologs were found to be cleaved in certain 
organism are not in others (Ussat et al., 2000). The disparity of substrate cleavage 
across organism type is likely to influence the interpretation of the functional role of 
the substrate in processes mediated by caspase activity. This is particularly important 
in therapeutic and translation research where observations of substrate cleavage in 
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model organisms are often extrapolated to human studies. These annotations are 
obtained from the original literature reporting the caspase substrate. 
Uniprot ID: The Uniprot Accession ID for the substrate. A link to the protein 
entry in Uniprot databases is provided. 
Cleavage Site(s): The caspase cleavage site(s) on the substrate as reported in 
literature. In cases of erroneous or ambiguous data, the Uniprot sequence is stated 
instead. Sequence of cleavage site is reported in format suggested by Schecter and 
Berger (2000), followed by the location of scissile bond cleavage (numbering 
indicates the position of P1 residue). 
Cleavage Effect(s): A brief description of the consequence of substrate 
cleavage as reported in literature. For substrates derived from the Fischer dataset, the 
comments from Fischer et al. are used. 
Caspase(s) Involved:  The caspase(s) which is (are) shown to be responsible 
for cleavage of the substrate as reported in literature.  
Comments: Comments related to the cleavage of substrate. Cleavage of 
substrates assigned as “putative” is noted here. 
Sequence: The link to retrieve a protein sequence of substrate in FASTA 
format. 







   
Figure 2-2 Databases Interconnectivity Chart. 
Schematic diagram showing the Caspase Substrates 
Database links to key public databases. Solid lines 
represent direct links to the databases. Dashed lines 
































Figure 2-3 The Caspase Substrates Database
options for querying the database. Three 
Casbase Accession ID or Uniprot Accession ID, (ii) using keywords such as 
protein names or gene names, and (iii) using similarity searches via BLASTP.
 
 Query Page.  Page displays 

















Figure 2-4 The Caspase Substrates Database Details Page. Page displays 
the data on a database entry (e.g. PARP-1 protein). Page is populated with 





In this chapter, the problem of data for prediction of caspase substrates was 
discussed. Specifically, the lack of accurate and readily available data on bona fide 
caspase substrates is a limiting factor for studies on caspase-mediated substrate 
cleavage as well as the development of appropriate prediction tools. Consequently, a 
systematic approach was carried to extract the relevant data from published literature. 
A dataset of 313 experimentally verified caspase substrates (updated to 31 May 2008) 
was constructed after data retrieval. To facilitate efficient storage and retrieval of data, 
a relational database was development and is accessible at 
http://www.casbase.org/casvm/squery/index.html. The content of chapter has been 
published in Wee LJ, Tan TW, Ranganathan S. CASVM: web server for SVM-















Chapter 3: Prediction of caspase cleavage sites 
3.1 Introduction 
As discussed in Chapter 1, substrates of caspases belong to a myriad of protein 
classes such as structural elements of cytoplasm and nucleus, components of the DNA 
repair machinery, protein kinases, GTPases and viral structural proteins. Although 
more than 280 caspase substrates have been discovered to date, it is possible that 
several more remain undetected. The identification and characterization of caspase 
substrates is critical for deepening our understanding of the role of these enzymes in 
the various cellular pathways. However, the accurate detection of caspase cleavage 
sites in target proteins requires complex and time consuming in vivo and in vitro 
experiments. Given the readily available sequence data in public databases, a useful 
alternative is to conduct in silico screening for potential cleavage sites among 
proteins. While the preferential cleavage specificities may be useful here, recently 
identified substrates have shown significant variation in their cleavage sites (Fischer 
et al., 2003). Therefore, the development of computational tools to accurately capture 
complex sequence patterns and to automate the identification of new cleavage sites 
would be valuable.  
A number of caspase substrate cleavage prediction methods currently exist. 
All methods are based on the detection of caspase cleavage sites on potential 
substrates (primary features of these methods are summarized in Table 3-1). The 
pioneering work began with PeptideCutter, a proteases substrates cleavage prediction 
server for various families of proteases (Gasteiger et al., 2003). Due to the scarcity of 
experimental data, PeptideCutter was based only on the preferential cleavage 
specificities of certain caspases (Thornberry et al., 1997). Lohmuller et al. (2003) 
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developed the peptidase substrate prediction tool (PEPS) based on position specific 
scoring matrices (PSSM) for cathepsin B, cathepsin L and caspase-3 substrates. While 
useful, the utility of these tools is limited as they were built on a small dataset of 
cleavage sites and the cleavage specificities are confined to certain caspases alone, 
rather the entire family. In recent years, the exponential discovery and 
characterization of new substrates and their cleavage sites enabled the development of 
more effective algorithmic tools. Garay-Malpartida et al. (2005) developed the 
CasPredictor software which exhibited an improvement over previous methods with 
an accuracy of 81% on a dataset of 137 experimentally verified cleavage sites. The 
CasPredictor software uses an algorithm which analyzes the cleavage sites for amino 
acid substitution, amino acid frequency and the presence of ‘PEST’ sequences in the 
vicinity of the cleavage site (flanking 10-15 residues). The GraBCas software by 
Backes et al. (2005) advanced the previous PSSM-based methods by including an 
updated set of caspase cleavage specificities based on the work by Thornberry et al. 
(1997), and observing conservation at P1’ and even P2’ positions. Yang (2005) 
experimented with different neural networks for predicting cleavage sites such as 
single-layer perceptrons, multi-layer perceptrons and the Bayesian bio-basis function 
neural networks. They achieved an accuracy of 97% using the Bayesian bio-basis 
function neural network with two Gaussian distributions. In the same study, the 
support vector machines (SVM) method was tested and was found to give excellent 
results. However, Yang used a small dataset of 13 sequences and the method is not 
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In this chapter, a support vector machine (SVM) system was developed to 
predict for potential caspase substrate cleavage sites on protein sequences. First 
introduced by Cortes and Vapnik (1995), the SVM method is a relatively new sub-
branch of the machine learning algorithms. SVM has been shown to perform well in 
diverse computational biology applications such as the prediction of protein 
secondary structure (Hua and Sun, 2001; Ward et al., 2003; Nguyen and Rajapakse, 
2005); protein fold (Ding and Dubchak, 2001); protein quaternary structure (Zhang et 
al., 2003); protein homology (Busuttil et al., 2004); protein-protein interaction sites 
(Bradford and Westhead, 2005); protein domains (Vlahovicek et al., 2005), HIV 
protease cleavage sites (Cai et al., 2002) and T-cell epitopes (Zhao et al., 2003). It is 
also used in the classification and validation of cancer tissue samples (Furey et al., 
2000) and microarray expression data (Brown et al., 2000). Other applications of 
SVMs in biology have been reviewed by Byvatov and Schneider (2003), and Yang 
(2004). An extensive dataset of unique (non-redundant) cleavage sites extracted from 
the datasets of experimentally verified caspase substrates (from Fischer and Post-
Fischer datasets) was constructed to validate the SVM method and to further the 
development of other computational tools. Using various statistical metrics, the SVM 
method was shown to be a rigorous and effective approach for predicting cleavage 









3.2 Results and Discussion 
A cleavage sites dataset containing 195 and 24 unique caspase cleavage site 
sequences were constructed from the Fischer and Post-Fischer datasets respectively. 
The 195 sequences were used for training the SVM classifier while the 24 sequences 
were used for testing the effectiveness of the SVM method. As there were no 
experimentally reported non-cleavage sites for caspases, tetrapeptide sequences were 
extracted at random positions (not including the cleavage sites) on experimentally 
determined caspase substrates. One non-cleavage site was extracted for every 
cleavage site on the same substrate. The assumption that an intuitively large 
proportion of tetrapeptide sequences other than the cleavage sites(s) on the same 
substrate should not be recognized and cleaved by caspases justify the use of these 
sequences as non-cleavage sites. An equal number of these non-cleavage sites were 
extracted to match the cleavage sites. Together, a primary dataset consisting of the 
tetrapeptide cleavage sites (positive sequences) and non-cleavage sites (negative 
sequences) was constructed and designated as the P4P1 dataset (Figure 3-1). 
Previously, Backes et al. (2005) and Garay-Malpartida et al. (2005) suggested 
that residues adjacent to the cleavage site may influence substrate cleavage. Backes et 
al. reported the high occurrence of specific amino acids at P1’ for caspase-3 and P1’ 
and P2’ for granzyme B, a serine protease involved in apoptosis and in immune 
response (Lord et al., 2003). Garay-Malpartida et al. reported that a sizeable 
proportion of cleavage sites are localized within ‘PEST’ regions, of which have been 
suggested to label proteins for protease degradation. PEST regions are defined as 









proline (P), glutamate (E), aspartate (D), serine (S) and threonine (T) residues (Rogers 
et al., 1986; Rechsteiner and Rogers, 1996).  Therefore, to investigate the influence of 
the adjacent sequences on substrate cleavage, a dataset containing tetrapeptide 
sequences with the P1’ and P2’ residues and a dataset containing tetrapeptide 
sequences flanked by ten residues on either side of the cleavage site were constructed. 
These datasets were designated as P4P2’ and P14P14’ respectively (Figure 3-1). The 
longer sequence segments would encapsulate the information contained in the critical 
tetrapeptide sequences as well as the P1’ and P2’ amino acids and other residues 
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Figure 3-1 Different subsequence segments for SVM training and testing. For human 
Mcl-1 [Swiss-Prot: Q07820], a sequence window of 24 amino acids in length centred on the 
tetrapeptide cleavage site, TSTD (underlined) is shown. Amino acids to the left of the 
scissile bond (shown by the inverted triangle) are labelled from P1 (D) to P14 (L). Amino acids 
to the right of the scissile bond are labelled from P1’ (G) to P10’ (A). Curly brackets indicate 
the subsequence segments extracted for SVM implementation. The sequences spanning P4 
to P1 (TSTD), P4 to P2’ (TSTDGS) and P14 to P10’ (LELVGEGSNNTSTDGSLPSTPPPA) are 






















Next, the P4P1, P4P2’ and P14P14’ datasets were divided into training and test 
datasets (Figure 3-2).  The training datasets were used for optimizing the SVM 
parameters and for training the SVM classifier, while the test datasets were used for 
evaluating the SVM method. The RBF kernel, with parameters γ and C, was chosen 
for SVM implementation. Using 10-fold cross-validation, the parameters γ and C 
were optimized at 0.01 and 100 (for P4P1 training dataset) and 0.1 and 100 (for both 
P4P2’ and P14P10’ training datasets). For each of P4P1, P4P2’ and P14P10’ training 
datasets, an overall accuracy of 98.97% was obtained during the cross-validation. 
 Primary dataset 

















Test dataset  
(48 sequences) 
Figure 3-2 Schematic layout of the datasets used for SVM training and testing. The 
primary dataset consist of non-redundant tetrapeptide caspase substrate cleavage sites 
obtained from literature and an equal number of non-cleavage sites. 1The P4P1 sequences 
consist of all the sequences in the primary tetrapeptide cleavage site dataset. P4P2’ and P14 
P10’ datasets were derived by extracting subsequence segments from the parent protein 
chains in the vicinity of the tetrapeptide cleavage sites, as shown in Figure 3-1. All datasets 




While the reported accuracy on the training datasets may indicate the 
effectiveness of a prediction method, it may not accurately portray how the method 
will perform on novel, hitherto undiscovered cleavage sites. Therefore, testing the 
SVM methodology on independent out-of-sample datasets not used in the cross-
validation is critical. The SVM classifiers, trained separately using the entire training 
datasets from the P4P1, P4P2’ and P14P10’ datasets with the optimized γ and C 
parameters, were applied on the respective test datasets and results were evaluated. As 
shown in Table 3-2, for the P4P1 test dataset, the SVM method obtained an accuracy 
of 95.83% using the RBF kernel with γ=0.01 and C=100. For both the P4P2’ and 
P14P10’ test datasets, the SVM method obtained an accuracy of 97.92% using the RBF 
kernel with γ=0.1 and C=100. 
An analysis on the training and test datasets indicated a large percentage of 
cleavage sites with the XXXD motif (~98%) and a very small percentage of cleavage 
sites with a non-canonical XXXE motif (~2%). While experimental cleavage site 
specificities reported in Thornberry et al. (2007) suggest most, if not all, sequences to 
conform to the XXXD motif, the inclusion of a large proportion of these sequences in 
the development of the SVM system could lead to over-training of the classifier and 
confound the results obtained with different sequence representations. To mitigate this 
possibility, datasets identical to P4P1, P4P2’ and P14P10’ datasets but with the P1 
residue removed in all the sequences (labeled as P4P1(-D), P4P2’(-D) and P14P10’(-D) 
datasets respectively) were constructed. These datasets were further divided into 
training and test sets and SVM parameters were optimized in the manner as reported 




Table 3-2 Results of SVM prediction for various test datasets 
 
1. The SVM parameters (γ and C) were obtained from the cross-validation conducted on the 
training datasets. 
 








AC (%) SE (%) SP (%) MCC 
P4P1 0.01 100 95.83 95.83 95.83 0.92 
P4P2
’ 0.1 100 97.92 95.83 100.00 0.96 
P14P10
’ 0.1 100 97.92 95.83 100.00 0.96 
P4P1(-D) 0.01 1 81.25 62.50 100.00 0.67 
P4P2
’(-D) 1 100 89.58 79.17 100.00 0.81 
P14P10
’(-D) 0.1 1 93.75 87.50 100.00 0.88 









P4P2’ and P14P10’ datasets. The trained SVM classifiers were tested on the respective 
test datasets. As shown in Table 3-2, the SVM method obtained an accuracy of 
81.25% for the P4P1(-D) test dataset. The performance of the SVM improved 
significantly when tested on P4P2’(-D) and P14P10’(-D) datasets as accuracy readings 
of 89.58% and 93.75% were obtained respectively. While the accuracy on all (-D) test 
datasets were lower compared to the corresponding original datasets, a larger degree 
of improvement was observed when the longer sequence representations were used, as 
evidenced by the greater spread in both the accuracy and sensitivity readings for the 
P4P1(-D),  P4P2’(-D) and P14P10’(-D) datasets. An analysis of the misclassified 
sequences showed that cleavage sites such as CLLD2193 from Notch1 [Swiss-
Prot:P46531] and PEVD142 from p23 co-chaperone [Swiss-Prot:Q15185], which 
differ markedly from reported tetrapeptide specificities, were misclassified by the 
P4P1(-D)-trained SVM, but were correctly predicted when the P4P2’(-D) and 
P14P10’(-D) datasets were used. Also, the SVM trained with the P4P1(-D) and P4P2’(-
D) datasets failed to correctly classify the non-canonical cleavage site VQPE205 from 
DIAP1 [Swiss-Prot:Q24306], but correctly predicted the cleavage site when trained 
with the P14P10’(-D) dataset. These results suggest that the SVM trained with the (-D) 
datasets may be useful for identifying hitherto undiscovered cleavage sites while 
circumventing the problem of overtraining due to the high percentage of “XXXD” 
cleavage sites in the training datasets. The results also provided further evidence for 
the suggestion that the P1’, P2’ and residues further upstream and downstream of the 
cleavage site may influence substrate cleavage, and by accounting for these flanking 
sequences, the SVM performance can be improved. It was also shown that the SVM 
method can be extended to predict cleavage sites with residues other than the 
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canonical aspartate (D) at P1. While the occurrence of the non-canonical cleavage 
sites remains proportionately small, it does imply that the sampling space is not 
limited to the XXXD motif for cleavage sites. Consequently, the ability to predict 
these non-canonical cleavage sites will be a useful complement to existing 
computational methods which assumes the consensus XXXD motif as the basis for 
their algorithms. 
As other methods were not readily accessible, only GraBCas could be used for 
direct comparison with the SVM method using the present datasets. Since the 
GraBCas method primarily focuses on the tetrapeptide motif, it was only applied to 
the P4P1 training dataset. As the GraBCas method can only be applied to potential 
cleavage sites with aspartate (D) at the P1 position, the positive sequences in the P4P1 
training dataset were scored with the GraBCas matrix values for the different caspases 
then selected for the highest score and checked for the percentage of correctly 
predicted cleavage sites (or Sensitivity, SE) against a series of cut-off scores. As 
shown in Table 3-3, the sensitivity values declined steadily from 87.43% to 19.76% as 
the cutoff values were progressively increased (0.1, 1, 5, 10, 20).  The GraBCas 
method was also tested on the positive sequences in the P4P1 test dataset. As there 
were no recommended cut-off scores for predicting the cleavage sites, the cut-off 
score of 0.1, as used for the granzyme B cleavage sites prediction in Backes et al. 
(2005), was chosen.  At the cut-off score of 0.1, GraBCas predicted only 16 out of 24 
cleavage sites correctly (SE = 66.67%). 
Finally, to investigate how the SVM method can complement experimental 
work on caspase substrate cleavage, the SVM method was used to predict the caspase-




Table 3-4 SVM prediction of caspase substrate cleavage sites in Livin 
and mutants 
 
Substrate1 Experimental Results2 SVM Prediction3 
Wild type Livin Cleaved Cleaved 
LE ∆52-61 Not Cleaved Cleaved 
∆53-55 Cleaved Cleaved 
∆55-57 Cleaved Cleaved 
∆57-59 Cleaved Cleaved 
∆60-62 Cleaved Cleaved 
∆52-61 Not Cleaved Not Cleaved 
∆53-61 Not Cleaved Cleaved 
∆52 Not Cleaved Not Cleaved 
∆51-53 Not Cleaved Cleaved 
 
1. Wild type Livin and various deletion mutants as reported in Yan et al. 
2. Experimentally verified cleavage (cleaved) or non-cleavage (not cleaved) of Livin and deletion 
mutants. 
3. SVM prediction of caspase cleavage sites on Livin and deletion mutants (Cleaved – presence 
of cleavage site; Not Cleaved –absence of cleavage site).  
 
 
sequences as reported in Yan et al. (2006), based on the prediction of the caspase 
cleavage sites. As shown in Table 3-4, the experimental cleavage of wild type human 
Livin and its deletion mutants were compared to the results predicted by the SVM 
trained with the P14P10’(-D) dataset. With the exception of the LE ∆52-61, ∆51-53 and 
∆53-61 mutants, all other sequences were correctly predicted to be cleaved or not 
cleaved by caspases as indicated. For the LE ∆52-61 and ∆51-53 mutants, the 
flanking sequences upstream and downstream of the cleavage site were likely to have 
influenced cleavage of the substrates, as predicted by the SVM. However, cleavage of 
substrates was prevented due to the absence of the Asp at P1 (DHVD52). While the 
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SVM predicted the cleavage of ∆53-61 mutant, it was proposed by Yan et al. (2006) 
that the deleted residues might have led to the distortion of the structure of a 
neighboring domain or affected its signaling function, which subsequently inhibited 
the substrate cleavage through downstream signaling. These findings suggest that the 
SVM-based prediction of caspase substrate cleavage sites might be helpful in 




The primary dataset contains 438 unique sequences (219 cleavage sites and 
219 non-cleavage sites). Of the 219 cleavage sites, 195 were obtained from the 
Fischer dataset and 24 from the Post-Fischer dataset. Besides the tetrapeptide 
cleavage site sequences, subsequence segments of varying lengths centred on the 
tetrapeptide cleavage sites were extracted as shown in Figure 3-1. In total, three 
groups of sequences were obtained: tetrapeptide cleavage sequences (henceforth 
termed as the P4P1 sequences), tetrapeptide cleavage sequences with the next two 
residues, P1’ and P2’ residues (P4P2’sequences), and tetrapeptide sequences with 
upstream residues up to P14 and downstream residues up to P10’ (P14P10’ sequences). 
The cleavage sites and the corresponding subsequences were designated as positive 
sequences for the SVM training and testing. 
The 219 non-cleavage sites were obtained by extracting tetrapeptide sequences 
at random positions (not including the cleavage sites) on caspase substrates. One non-
cleavage site was extracted for every cleavage site on the same substrate. 
Subsequence segments centred on these non-cleavage sites were also extracted in the 
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manner reported earlier. The non-cleavage sites and the corresponding subsequences 
were designated as positive sequences for SVM training and testing. Together, the 
positive and negative sequences in the three group of sequences were designated as 
the P4P1, P4P2’ and P14P10’ datasets respectively. Each of these datasets was further 
divided in the following manner (Figure 3-2): 
Training datasets:  Training datasets were used for optimizing the SVM 
parameters and for training the SVM classifier to predict unseen test examples. Each 
training dataset contain 390 sequences (195 positives and 195 negatives). The positive 
sequences were obtained from the Fischer dataset and are available in Appendix B 
(Table B-1). 
Test datasets: Test datasets were used for evaluating the performance of the 
SVM method. Each test dataset contains 48 sequences (24 positives and 24 
negatives). The positive sequences were obtained from the Post-Fischer dataset and 
are available in Appendix B (Table B-2). 
Datasets containing sequences identical to the P4P1, P4P2’ and P14P10’ datasets 
but without the P1 residue were also constructed (designated as P4P1(-D), P4P2’(-D) 
and P14P10’(-D) respectively). These datasets were divided into training and test 
datasets as mentioned earlier. 
3.3.2 Vector encoding schemes 
To encapsulate the sequence information into a format suitable for SVM 
training and testing, the sequences were transformed into n-dimensional vectors using 
an orthonormal encoding scheme. Each amino acid is represented by a 20-
dimensional vector, composed of either zero or one as elements. For example, alanine 
was represented as [0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1] and cysteine as 
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[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1,0]. Therefore, for the P4P1 dataset, each sequence 
was represented by an 80-dimensional vector. Sequences in the P4P2’ and P14P10’ 
datasets were represented by 120 and 480 dimensional vectors respectively. 
3.3.3 SVM implementation 
For SVM implementation, the freely downloadable LIBSVM package by 
Chang and Lin (2001) was used. Details of the SVM methodology can be obtained 
from the article by Burges (1998). Briefly, SVM is based on the structural risk 
minimization principle from statistical learning theory. A set of positively and 
negatively examples can be represented by the feature vectors xi (i = 1, 2,…, N) with 
corresponding labels yi  }{ 1,1 −+∈ . To classify the data, the SVM trains a classifier 
by mapping the input samples, using a kernel function in most cases, onto a high-
dimensional space, and then seeking a separating hyperplane that differentiates the 
two classes with maximal margin and minimal error. The decision function for new 
predictions on unseen examples is given as: 
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under the conditions,  








i yα  and Ci ≤≤α0  
 
The variable C serves as the regularization parameter that controls the trade-off 
between margin and classification error.  
As the effectiveness of the SVM prediction system is dependent on the type of 
kernel used, various kernels (linear, sigmoid, polynomial and the radial basis 
function) commonly implemented in biological problems was explored for this 
problem. Each of the kernel functions were tested on the training datasets and the 
widely used radial basis function (RBF) kernel as it was found to be most effective 
(data not shown). The RBF kernel function is given as: 
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With the RBF kernel, two parameters are required for optimizing the SVM classifier; 




3.3.4 SVM optimization 
To optimize the SVM parameters γ and C, 10-fold cross-validation was 
applied on each of the training datasets using various combinations of γ and C. In 10-
fold cross-validation, the training dataset was spilt into 10 subsets where one of the 
subsets was used as the test set while the other subsets were used for training the 
classifier. The trained classifier was tested using the test set. The process is repeated 
10 times using a different subset for testing, hence ensuring that all subsets are used 
for both training and testing. SVM parameters γ and C were stepped through 
combinations of 0.01, 0.1, 1, 10, 100 for γ, and 1, 10, 100 and 1000 for C in a grid-
based manner.  
3.3.5 SVM training and testing 
The best combinations of γ and C obtained from the optimization process were 
used for training the SVM classifier using the entire training dataset. The SVM 
classifier was subsequently used to predict the test datasets. Various quantitative 
variables were obtained to measure the effectiveness of the SVM method: 
 
(i) TP, true positives – the number of correctly classified cleavage sites. 
(ii) FP, false positives – the number of incorrectly classified non-cleavage sites. 
(iii) TN, true negatives – the number of correctly classified non-cleavage sites. 
(iv) FN, false negatives – the number of incorrectly classified cleavage sites.  
 
Using the variables above, a series of statistical metrics were computed to 
measure the effectiveness of the SVM method. Sensitivity (SE) and Specificity (SP), 
which indicates the ability of the prediction system to correctly classify the cleavage 
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To provide an indication of the overall performance of the system, we 
computed Accuracy (AC), for the percentage of correctly classified sites, and the 
Matthews Correlation Coefficient (MCC). 
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3.3.6 Prediction of caspase cleavage of Livin and mutants 
The SVM trained using the P14P10’ (-D) dataset (using RBF kernel, γ =0.1, 
C=100) was used to predict the cleavage of Livin [Swiss-Prot:Q96CA5] and the 
various deletion mutants, based on the prediction of the caspase cleavage sites, as 
reported in Yan et al. (2006). 24 amino acids subsequence segments centred on the P1 
residue of the reported Livin cleavage site (DHVD52) were extracted from both wild 
type and mutant Livin sequences. Mutants used in this study are: LE ∆52-61, ∆53-55, 
∆55-57, ∆57-59, ∆60-62, ∆52-61, ∆53-61, ∆52 and ∆51-53. In mutants with Asp-52 
deleted, the peptide windows were centred on the subsequent residue occupying 
position 52.  
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3.3.7 Comparison with other available methods 
As the CasPredictor method is unavailable from the published website, it was 
not tested. The performance of GrabCas was compared with the SVM method using 
the current datasets. As the GraBCas scoring matrices are specific for the tripeptide, 
P4-P3-P2, and assume that P1 is an Asp (D) residue, the GraBCas matrices were used 
to score only the positive sequences (cleavage sites) from the P4P1 training dataset. As 
GraBCas scores for different caspases were available, only the highest scores were 
recorded. The percentage of correctly predicted cleavage sites (Sensitivity, SE) were 
calculated as mentioned earlier. GraBCas was further tested on the P4P1 test dataset in 


















3.4  CASVM: Server for SVM prediction of caspase cleavage sites 
3.4.1 Server description 
A web server, CASVM, was developed for the SVM-based prediction of 
caspase substrates cleavage sites as discussed earlier. It is written in Perl and is hosted 
on a Linux platform accessible at http://www.casbase.org/casvm/server/index.html.  
The server homepage presents an intuitive interface for user input and 
processing (Figure 3-3). Users can submit (through copy and paste) a raw or FASTA-
formatted protein sequence and select a number of options for server prediction. Upon 
form submission, the input sequence will be scanned over the entire length of the 
sequence with the scanning window selected by the user. Three scanning window 
sizes are available: P4P1, P4P2’ and P14P10’, each dictating the type of SVM classifier to 
be used for prediction. For example, if the scanning window size of P14P10’ is selected, 
the P14P10’-trained SVM classifier will be used for prediction. The P14P10’-trained 
classifier, having reported the highest accuracy during our experimentation, is 
selected as default. There is also the option for the selection of the type of P1 residue 
to be screened so as to account for the possibility of non-canonical cleavage sites on 
substrates. Users are able to select for aspartic acid (default) or both aspartic acid and 
glutamic acid as the required P1 residue. As the input sequence is being scanned, 
sequence segments containing the specified P1 amino acid will be extracted and 
predicted for the presence of the cleavage site with the selected SVM classifier.  
The output of the CASVM prediction displays the name of input sequence 
(optional), sequence length, an abbreviated version of the sequence, a list of potential 
cleavage sites (all tetrapeptide sequences with the specified P1 residue in the input 
sequence) and the CASVM-predicted cleavage sites. All cleavage sites are labelled 




An analysis of the cleavage sites datasets (available in Appendix B: Table B-1 
and Table B-2) revealed that a large number of caspase cleavage sites differ markedly 
from the consensus tetrapeptide specificities. More significantly, although caspases 
are thought to be selective for aspartic acid at the P1 position, a notable number of 
substrates were cleaved at tetrapeptide sites bearing glutamic acid at the P1 position. 
Interestingly, existing methods for caspase cleavage sites prediction (excepting the 
method herein) are largely limited to the discovery of cleavage sites with aspartic acid 
at P1 as they assume the consensus XXXD motif as the basis for their algorithms. The 
strict adherence to the inclusion of aspartic acid may be limiting the sensitivity of 
these tools since it is intuitively likely that many more substrates will have P1 residues 
as glutamic acid. Therefore, the option on the server to screen and predict for 
tetrapeptide sequences containing either aspartic acid or glutamic acid at the P1 
position would be helpful. In addition, as the substrates used in the method are 
derived from a variety of organisms (human, mouse, rat, fruit fly, cow, chicken, frog, 
worm and viruses) and are cleaved by various caspases (caspase -1, -3, -6, -7, -8, -9, -
12, -13 and -14), the server is applicable to the detection of cleavage sites in 















Figure 3-3 CASVM server page. A web form allows users to submit a raw or FASTA-














Figure 3-4 The results of prediction on CASVM server. A list of all predicted cleavage 





In conclusion, a support vector machines (SVM) approach for predicting 
caspase cleavage sites was developed and was shown to be complementary to existing 
methods, if not more effective. The prediction accuracy can also be improved by 
accounting for sequences at the P1’ and P2’ positions and further upstream and 
downstream of the cleavage site. In addition, the SVM method may be useful for 
predicting the non-canonical cleavage sites lacking aspartic acid the P1 position, such 
as those found in DIAP1 and other proteins as reported in literature. CASVM, a web 
server implementing the SVM method was developed. Also, an extensive dataset of 
unique, experimentally-verified caspase substrates cleavage sites was constructed and 
is made available on the CASVM server website. The content of this chapter has been 
published in Wee LJ, Tan TW, Ranganathan S. SVM-based prediction of caspase 
substrate cleavage sites. BMC Bioinformatics. 2006, Suppl. 5:S14 and Wee LJ, 
Tan TW, Ranganathan S. CASVM: web server for SVM-based prediction of 













Chapter 4: Towards the prediction of caspase substrates  
4.1 Introduction 
As discussed in Chapter 3, current approaches for caspase substrates 
prediction are based on the detection of potential cleavage sites on proteins using 
information encoded within the tetrapeptide motifs. While the identification of the 
specific cleavage site on the primary sequence of a protein is necessary for substrate 
prediction, it is intuitive that the final proteolytic cleavage of a protein is likely the 
outcome of a multitude of factors in addition to the presence of cleavage sites 
(Timmer and Salvesen, 2007). There is evidence to suggest that conformation of the 
local structure of the cleavage site and not just the primary sequence alone is required 
for protease cleavage. An analysis on a dataset of 176 caspase substrates (derived 
from the Fischer dataset), 80% of substrates contain at least one other caspase 
cleavage site which is not reported as the true cleavage site in literature. The cleavage 
sites of Tpr (DDED) [Ferrando-May et al., 2001), p28BAP31 (AAVD) [Ng et al., 
1997; Granville et al., 1998; Maatta et al., 2000], golgin 160 (SEVD) [Mancini et al., 
2000], Topo I (PEDD) [Casiano et al., 1998; Samejima et al., 1999] and 
heterogeneous nuclear ribonucleoparticle C1/C2 (GEDD) [Waterhouse et al., 1996], 
are located at two distinct positions on the respective protein but only one was 
reported to be cleaved. Recent studies have suggested that unstructured regions of 
substrates appear to be more susceptible to cleavage than regions of secondary 
structure (such as helices and β-sheets) (Timmer and Salvesen, 2007). Indeed, a 
number of in vivo caspase substrates with reported structures suggest that cleavage 
sites have a preference for disordered or unstructured extended loops, in line with 
observations on protease substrates in general.  It is further suggested that the location 
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of cleavage sites may be important as well –a potential cleavage site needs to be 
located at the surface of the substrate, rather than within the hydrophobic core of the 
protein, in order to be accessible to the protease active site (Boyd et al., 2005). 
In this context, it is opportune to quantify the relationship between factors for 
caspase substrate cleavage and to improve on existing methods for substrate 
prediction. In this chapter, studies conducted indicate that caspase cleavage sites have 
a higher propensity to be located in disordered or unstructured extended loops and in 
solvent exposed regions compared to non-cleavage sites. A quantitative model 
combining these factors with the previously developed SVM-based method for 
predicting caspase cleavage sites was developed to refine the prediction of caspase 
substrates. The multi-factor model was shown to improve accuracy by reducing the 
false positives from predicted cleavage sites based on different methods. 
 
4.2 Materials and Methods 
4.2.1 Dataset 
74 unique, experimentally verified cleavage sites were obtained from the 
dataset of caspase cleavage sites derived from Fischer et al. (2003). 24-residue long 
subsequences comprising of the tetrapeptide sequence with flanking upstream 10 
residues and downstream 10 residues (P14....P4P3P2P1......P10’) were extracted and 
assigned as “cleavage sites”. For every cleavage site, one other tetrapeptide was 
randomly selected on the respective substrate and subsequences similar in length to 
the cleavage site sequences were constructed. A total of 74 additional subsequences 
were constructed and designated “non-cleavage sites”. Together, the sequences 
constitute the analysis dataset (total 148) and were used for analysis of structural 




4.2.2 Quantitative measures of secondary structures and solvent accessibilities 
Each sequence in the analysis dataset was predicted for secondary structures 
and solvent accessibilities using the SABLE II protein structure prediction server 
(w/approximator predictor selected, server located at http://sable.cchmc.org) (Wagner 
et al., 2005; Adamczak et al., 2004; Adamczak et al., 2005). SABLE server output 
was parsed with Perl scripts and quantitative measures of the propensities for helices 
(Hp), b-strands (Ep), coils (Cp) and solvent accessibilities (Sp) were computed using 
the following equations: 
   
 
	  
    





     








Where Hn, Ep, Cp and Sn are the predicted secondary structure for helix, beta-strand, 
coil and real-value score (ranging 0-6, 0 for fully buried and 6 for maximum 
exposure) for solvent accessibility for each residue at position n in the sequence of 
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length N (=24). Smax is given a value of 144 (=24 x 6), which is the sum of real-value 
scores for all residues in the sequence assuming that each residue is maximally 
exposed to solvent. 
 
The variable, P-score, which is a combinatorial measure of the propensity for 
unstructured regions and solvent exposure, was calculated for all sequences in the 
analysis and test datasets as:  




The coefficients α and β represent the respective fractional weighting of Cp and Sp in 
the P-score variable. Optimal α and β coefficient values were obtained by stepping 
through various combinations of values (0.0, 0.1, 0.2…1.0), and measuring the 
percentage of cleavage sites and non-cleavage sites retained at increasing P-score cut-
offs. 
4.2.3 Multi-factor model testing  
For model testing, a test dataset of unique caspase cleavage sites (17 
sequences) from the Post-Fischer dataset was used. The test dataset was predicted for 
potential caspase cleavage sites using CASVM server and GraBCas algorithm using 
default options. Predicted caspase cleavage sites were extracted from substrate 
sequences and 24-residue long subsequences comprising of the predicted tetrapeptide 
sequences with flanking upstream 10 residues and downstream 10 residues 
(P14....P4P3P2P1......P10’) were constructed and calculated for Sp, Cp and P-score values. 





4.3.1 Propensity for unstructured regions 
Here, it is hypothesized that the cleavage sites of caspase substrates are likely 
to locate in unstructured segments spanning across the tetrapeptide sequence on the 
folded protein. To measure the propensities for secondary structures across the 
cleavage site region, 24-mer peptide subsequences comprising of the tetrapeptide 
cleavage site with upstream 10 residues up to P14 and downstream 10 residues up to 
P10’ was constructed from respective substrates in the analysis dataset and predicted 
for secondary structural elements using SABLE II protein structure prediction server. 
The propensities for secondary structures were quantified as Hp, Ep and Cp scores for 
helices, beta-strands and coils respectively. As shown in Fig 4-1(A), the propensity 
for coils were significantly greater for cleavage sites sequences compared to non-
cleavage sites (mean Cp=0.76 versus Cp=0.51 respectively, P-value<0.01), while the 
propensity for helices were greater for non-cleavage sites compared to cleavage sites 
(mean Hp=0.43 versus Hp=0.21 respectively, P-value<0.01). The distribution of 
cleavage sites and non-cleavage sites were further analyzed across Cp bins (Fig 4-1B). 
It was shown that cleavage sites were distributed more frequently to bins of higher Cp 
scores compared to non-cleavage sites. Most cleavage sites were confined to bins 0.8-
1.0 while a greater proportion of non-cleavage sites were distributed to bins less than 
0.8. These results suggest that caspase substrate cleavage sites tend to locate in 







4.3.2 Propensity for solvent exposure  
It is also hypothesized that cleavage sites will preferentially locate in solvent 
exposed regions of substrates. Therefore, the solvent accessibilities of the 24-mer 
peptide subsequences from the analysis dataset were predicted. Using the SABLE II 
server, real-value scores for each 24-mer subsequence were obtained and computed a 
score, Sp for measuring the propensity for solvent exposure. As shown in Figure 4-
2(A), sequences containing cleavage sites were on the average, more exposed to 
solvent compared to non cleavage sites (mean Sp = 0.50 versus Sp=0.43 respectively, 
P-value < 0.01). The distribution of sequences, with or without cleavage sites across 
Sp bins (Figure 4-2B) was further analyzed. Both cleavage and non-cleavage sites 
were found to be increasing distributed into regions of greater solvent exposure as Sp 
increases from 0 to 0.40. However, distribution of non-cleavage sites peaked at Sp of 
0.40, while the distribution for cleavage sites peaked at 0.60, before falling off at 
higher Sp bins values. These results suggest that caspase cleavage sites tend to locate 










Figure 4-1 Propensity for secondary structures. (
elements (coils, Cp; helices
caspase cleavage sites (label
of “cleavage sites” and “non


































A) Propensities for different secondary structure 
, Hp; beta-strands, Ep) were measured for 24-mer sequences with or
ed “cleavage sites” and “non-cleavage sites” respectively). (B) Distribution 
-cleavage sites” to Cp bins. Each Cp bin (0.10, 0.20...1.00) was allocated a 
















Figure 4-2 Propensity for solvent accessibility. (
measured for 24-mer sequences with or withou
“non-cleavage sites” respectively). (B) Distribution of “
bins. . Each Sp bin (0.10, 0.20...1.00) was allocated a proportion of sequences with S





























A) Propensities for solvent accessibilities (S
t caspase cleavage sites (labeled “











cleavage sites” and 
-cleavage sites” to Sp 








Figure 4-3 Scatter plots of Sp and Cp values for cleavage sites (A) and non-cleavage sites (B). 






































4.3.3 Multi-factor model for prediction of caspase substrates 
The major factor determining caspase cleavage is the presence of specific 
tetrapeptide sequences recognized by caspases. With the exception of GraBCas and 
CASVM, computational tools rely primarily on these sequences in their algorithms 
for prediction. However, as mentioned earlier, the usage of tetrapeptide specificities 
solely for detection of substrate cleavage is likely to produce a high percentage of 
false positives. Given that bona fide cleavage sites tend to locate in unstructured and 
solvent exposed regions, it is hypothesized if these two factors can be used to improve 
the prediction of caspase substrates by filtering out predicted sequences with 
unfavorable structural characteristics. Accordingly, a model is proposed for prediction 
of caspase substrates using a two-step approach. In the first step, a set of potential 
caspase cleavage sites is predicted for a given protein sequence using the relevant 
cleavage site prediction tool. In the second step, predicted sequences locating in 
highly structured and solvent inaccessible regions will be eliminated, leaving behind 
sequences with greater likelihood for cleavage. Here, to account for structural factors, 
24-mer sequences consisting of the predicted tetrapeptide sequences and upstream and 
downstream flanking residues are constructed, and values for Sp and Cp are calculated. 
Further analyses indicate a positive correlation between Sp and Cp values across 
cleavage sites and non-cleavage sites (Figure 4-3, overall correlation coefficient, r = 
0.43). Accordingly, the Sp and Cp values are combined into a single variable; P-score 
with optimized weightings of both factors selected at 0.7 and 0.3 respectively (data 
not shown). Based on the P-score, cut-off levels are assigned where predicted 
sequences from the first step scoring above the cut-off are retained while the rest are 
eliminated. The two-step model is further illustrated in Figure 4-4. 
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To corroborate the model, two distinctive caspase cleavage sites prediction 
tools, CASVM (described in Chapter 3) and GraBCas (Backes et al., 2005), were 
utilized. CASVM uses the support vector machines algorithm for prediction and has 
an optimal sensitivity of 89% when tested on an independent dataset of caspase 
cleavage sites. GraBCas, on the other hand, utilizes position-specific scoring matrices 
for scoring tetrapeptide sequences and achieved a sensitivity of 70% (cut-off > 0.1) 
using the same independent dataset. The test dataset consists of 14 caspase substrates, 
with a total of 17 unique caspase cleavage sites. Stepping through the first stage of the 
model, CASVM predicted 80 tetrapeptide sequences across all substrates as potential 
caspase cleavage sites, including all 17 cleavage site sequences from the test dataset. 
On the hand, GraBCas predicted a total of 223 tetrapeptide sequences, with only 15 
out of the 17 true cleavage sites included in the prediction results. Here, all predicted 
caspase cleavage sites verified as cleaved were assigned to be true positives and all 
others to be false positives. At the stage, all sequences (true positives and false 
positives) were calculated for their P-score values and filtered through cut-off values 
of increasing stringency. As shown in Figure 4-5(A), all CASVM predicted sequences 
were retained at P-score of 0 but were steadily eliminated as the cut-off progressed to 
1.00. In addition, at all P-score cut-offs, proportionately more true positives were 
retained compared to the false positives. At P-score of 0.50, about 88% of true 
positives were retained but more than half of the false positives were eliminated. 
Similar results were obtained when CASVM was replaced with GraBCas at the first 
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Figure 4-4 Schematic diagram of the two-step model for caspase substrate prediction. Step1: A 
window scans the entire protein (example: 14-3-3, Uniprot ID: P31946) for potential caspase cleavage 
sites (bold, underlined) using a caspase cleavage site prediction tool (a 24 residue window from CASVM 
shown as example). Step 2: Predicted cleavage sites are extracted together with flanking 10 residues 
downstream and upstream from the tetrapeptide sequence (P14 to P10’). Cp, Sp and P-scores are 
calculated for all subsequences. Subsequences are ranked according to their P-scores and filtered 
using the desired cut-off score. 
 
Cp, Sp and P-scores are calculated 
for all 24-mer sequences 
containing CASVM-predicted 
cleavage sites. 
24-mer sequences are ranked 




As shown in Figure 4-6, all sequences were eliminated in tandem with the 
increase in the P-score cut-off but proportionately more true positives were retained at 
all P-score cut-offs compared to false positives. Interestingly, results obtained using 
GraBCas showed that false positives elimination began at P-score cut-off of 0.20 and 
for true positives, at 0.55. When CASVM was used, false positives were eliminated 
onwards from P-score cut-off of 0.15 and true positives from 0.35. The higher P-
score cut-off for true positives in both cases suggest that the model is likely to 
improve substrate prediction accuracy since a notable proportion of false positives (up 
to 13% and 53% in CASVM and GraBCas models respectively) can be eliminated 
without reduction in the original pool of true positives. Taken together, these results 
further indicate that structural factors such as secondary structures and solvent 
accessibilities can be effective as additional factors for identifying bona fide caspase 
cleavage sites. Specifically, accuracy of substrate prediction can be improved when 
these factors are used for differentiating the true positives and false positives from 
results obtained through cleavage sites prediction tools.  
 
4.4 Discussion 
In this chapter, a computational model was implemented for the prediction of 
caspase substrates using a two-step approach. The entire protein sequence is first 
scanned for potential cleavage sites using a caspase cleavage sites prediction 
algorithm. The predicted cleavage sites are filtered through a scoring system which 
quantifies the propensities of predicted cleavage sites to locate in unstructured and 
solvent exposed regions on the protein. The incorporation of additional factors, such 







Figure 4-5 Results of caspase substrate prediction model on test dataset. CASVM predicted cleavage sites were assigned to pools containing “true 





































Figure 4-6 Results of caspase substrate prediction model on test dataset. GraBCas predicted cleavage sites were assigned to pools containing “true 



































substrates prediction (You, 2006). There, a three-level hierarchical classifier scans a 
protein sequence for HIV protease cleavage sites using specificity data and filters the 
output for sequences located within disorganized secondary structures and solvent 
exposed regions. These structural factors were similarly integrated into the neural 
network algorithms for RNA and DNA binding sites prediction and were found to be 
effective (Ahmad et al., 2004; Jeong et al., 2004). Here, instead of combining the 
prediction of cleavage sites specificity, secondary structures and solvent accessibilities 
into a single predictor, these factors were accounted in two distinct steps for the purpose 
of addressing a couple of caveats implicit in protease substrate prediction. While 
cleavage sites were shown to preferentially locate in unstructured and solvent exposed 
regions, not all predicted cleavage sites with substantial propensity for these factors are 
cleaved in vivo (Timmer and Salvesen, 2007). It is conceivable that regulatory processes 
such as post-translational modifications and other protein-protein interactions will also 
influence the final proteolytic event. Conversely, predicted cleavage sites sequences 
which are hidden in deep hydrophobic cores of proteins – and characterized by low 
propensities for solvent exposure – cannot be ruled out as it is possible that these 
sequences may be exposed following a proteolytic cleavage of the protein. Evidently, the 
caspase-mediated cleavage of ETK (epithelial and endothelial tyrosine kinase) was 
suggested to proceed in a two-step fashion where the first caspase cleavage site of the 
protein exposes an internal cleavage site for subsequent cleavage (Wu et al., 2001). The 
retinoblastoma protein, RB, the hepatocyte growth factor receptor, MET and GTP 
exchange factor for small G-protein Ras, RasGAP were all shown to be cleaved 
sequentially at multiple sites, suggesting the possibility of structural changes following an 
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upstream proteolytic cleavage event (reviewed in Fischer et al., 2003). To circumvent 
these constraints, the present model proposes a broad pool of potential cleavage sites 
which can be narrowed down through a range of P-score cut-off levels as guided by 
experimental data and user requirements. 
The two-step model was tested using two cleavage site prediction methods–
CASVM and GraBCas. It was shown that in both cases, the discrimination of prospective 
cleavage sites based on additional structural characteristics would be helpful for reducing 
false positives. The GraBCas model outperformed the CASVM model by eliminating a 
greater percentage of false positives before the first reduction in true positives. One 
possibility for the disparity could be the different sequence windows used for analysis in 
each case. GraBCas requires only the tetrapeptide cleavage sequence while a 24-mer 
peptide (tetrapeptide sequence with flanking 10 residues upstream and downstream) is 
needed for input into CASVM. Presumably, in the latter case, information encoding 
factors for cleavage sites specificity would have overlapped to a greater extent with that 
for secondary structures and solvent exposure. In any case, the results suggest that other 
cleavage sites prediction tools utilizing algorithms with low correlation with secondary 
structure and solvent accessibility prediction could be integrated into the model. 
Conversely, the addition of other factors with low correlations with cleavage site 
prediction would be helpful for improving prediction accuracy. Recent studies have 
suggested that exosites-interaction sites distal from the enzyme active site-could mediate 
substrate cleavage and are responsible for non-canonical caspase substrate cleavage. 
Structural studies by Agniswarmy et al. (2007) highlighted a symmetrical pentapeptide 
binding pocket on caspase-7 situated way from the active site which could function as an 
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exosite. Exosites was shown also to be involved in proteolytic events mediated by blood 
coagulation proteases (Bode et al., 1997). In addition, it was reported that serine 
phosphorylation of caspase cleavage sites, particularly on the P4 and P1’ residues, 
inhibited substrate cleavage (Tözsér et al., 2003). It is expected that the incorporation of 
these factors will be helpful for further reducing the false positives in prediction of 
caspase substrates.   
 
4.5 Conclusion 
In this chapter, the structural characteristics of reported caspase substrates were 
analyzed indicating that caspase cleavage sites tend to locate in unstructured and solvent 
exposed regions. A score-based two-step model was constructed to integrate these factors 
with existing cleavage sites prediction tools, CASVM and GraBCas. It was shown that 
the model improved accuracy by reducing false positives from cleavage sites prediction. 
As it is likely that other factors are involved in determining substrate cleavage, the 
development of algorithmic tools and availability of larger datasets will complement 
efforts in computational prediction. In concert with biochemical and biophysical studies, 
these in silico efforts will complement system-level studies on the caspase degradome 
and further our understanding of the intricacies of caspase-substrate biochemistry. In 
spite of the differences between protease degradomes, the prediction of specific substrate 
cleavage is likely to be largely influenced by a set of common factors such as the 
presence of the required cleavage site and its presentation. Therefore, with relevant and 
sufficient data, the model presented here can be reasonably extended for the prediction of 
other protease substrates as well. 
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Chapter 5:  
Caspase Cleavage of Receptor Tyrosine Kinases 
5.1 Introduction 
As a step towards elucidating the caspase degradome, the annotated human 
proteome, based on all protein entries reported in Swiss-Prot database (Release 51.4), 
was scanned for potential caspase cleavage sites using the CASVM server (with default 
options). The results showed that 12589 out of 15417 human proteins (~82%) in the 
Swiss-Prot dataset possess at least one caspase cleavage site. A similarly study on the 
proteome-wide prevalence of caspase cleavage sites was implemented by Garay-
Malpartida et al. (2005) using the CasPredictor software. In contrast, the CasPredictor 
software predicted 16.46% of proteins to possess at least one caspase cleavage site out of 
a dataset of 9986 proteins from Swiss-Prot database (release version not reported). It is 
not surprising that both prediction methods produced vastly differing results since they 
are developed on different algorithms. However, given the higher sensitivity of the SVM 
method, it is likely that the true percentage is greater than the latter. In any case, these 
results further support the expectation of many more caspase substrates are to be 
discovered in the future. 
In this chapter, a subset of the annotated human proteome - the family of receptor 
tyrosine kinases - was predicted for potential caspase substrates. Analyses on the results 
suggest a general mechanism of regulation of these proteins by caspase cleavage and 




5.2 Biochemistry of receptor tyrosine kinases 
 Protein kinases are enzymes that play a key regulatory role in nearly every aspect 
of cell biology (Roskoski, 2004). These enzymes tweak protein function through the 
catalysis of the transfer of phosphate groups from ATP molecules to specific amino acids 
on proteins. Based upon the nature of the target amino acid, these enzymes are classified 
as protein serine/threonine kinases or protein tyrosine kinases. They regulate a plethora of 
cellular functions such as apoptosis, cell cycle progression, cytoskeletal rearrangement, 
differentiation and development. Dysregulation of protein kinases occurs in a variety of 
diseases including cancer, diabetes, autoimmune, cardiovascular, inflammatory, and 
nervous disorders. Manning et al. (2002) identified 478 typical and 40 atypical protein 
kinase genes in humans (total 518) that correspond to about 2% of all human genes. The 
family includes 385 serine/threonine kinases, 90 protein tyrosine kinases, and 43 tyrosine 
kinase-like proteins. Of the protein tyrosine kinases, over 50 are receptor tyrosine kinases 
(or RTKs for short). The RTK family includes, among others, epidermal growth factor 
receptor (EGFR), platelet-derived growth factor receptors, fibroblast growth factor 
receptors (FGFRs), vascular endothelial growth factor receptors, Met (hepatocyte growth 
factor/scatter factor [HGF/SF] receptor), Ephs (ephrin receptors), and the insulin 
receptor.  
As reviewed in Hubbard and Miller (2007), RTKs are single-pass, type I receptors 
localized in the plasma membrane. Generally, RTKs are activated through ligand-induced 
oligomerization, usually dimerization, which juxtaposes the cytoplasmic tyrosine kinase 
domains. For most RTKs, this juxtaposition facilitates autophosphorylation in trans of 
tyrosine residues in the kinase activation loop or juxtamembrane region, inducing 
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conformational changes that stabilize the active state of the kinase. The phosphotyrosine 
residues on the intracellular region of the receptors serve as recruitment sites for the 
binding of signaling or adaptor proteins. These proteins redirect the trans-membrane 
signals into several distinctive pathways for cell proliferation and other important cellular 
responses. 
A common cellular signaling circuitry mediated by the RTK is typified in Figure 
5-1 using the HGF/SF receptor (or MET) as example (Tulasne and Foveau, 2008).  Upon 
ligand binding, activated MET receptor recruits SH2 domain containing proteins such as 
GrB2 to its phosphorylated docking sites on the cytoplasmic domain. Sos, a guanine 
nucleotide exchange factor for Ras, is recruited together with Grb2 to the activated 
receptor, leading to the activation of membrane bound Ras. Activated Ras activates Raf, 
which phosphorylates and activates other members of the MAP kinase cascade, 
culminating in the activation of MAP kinase, which translocates into the nucleus and 
stimulates transcription of survival genes such as Bcl-2 and Bcl-xL. An alternative, 
complementary pathway involves the binding of PI-3-kinase, another SH2 domain 
containing adaptor protein, to the activated MET receptor. Activated PI-3-kinase 
phosphorylates and activates PKB, which in turn, phosphorylates and inactivates Bad, a 
pro-apoptotic effector of the family of Bcl-2 proteins. Both downstream pathways, 
through counteracting external cell death signals and those initiated within the cellular 
milieu, fine tune the equilibrium of cell survival and death. For most RTKs, several other 
signaling pathways were found to propagate from the activated receptor through 
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Figure 5-1 Trans-membrane signaling in ligand-activated HGF/SF receptor (MET). Upon ligand binding, 
MET receptors dimerize and becomes activated through cross-phosphorylation of their cytoplasmic domains. 
These phosphotyrosine residues serve as binding sites for signaling molecules which propagate the signal into 





























interactions with diverse classes of molecules, as well as from signaling cross-talks 
with other membrane receptors such as the G-protein coupled receptors and cytokine 
receptors.  
As essential components of cellular signaling pathways mediating embryonic 
development, adult homeostasis and other critical processes, RTK activity in resting, 
normal cells is tightly controlled. It has been shown that mutations or structural 
aberrations in RTKs convert them to potent oncoproteins, contributing to the 
development and progression of many cancers. Consequently, RTKs and their cognate 
ligands have become rational targets for therapeutic intervention using humanized 
antibodies and small molecule drugs (Gschwind, 2004). In recent years, RTK-based 
cancer therapies have attained widespread clinical use for a number of cancer 
phenotypes – examples include trastuzumab (Herceptin) for metastatic breast cancer, 
imatinib (Glivec) for chronic myelogenous leukemia, gefitinib (Iressa) for non-small 
cell lung carcinoma, cetuximab (Erbitux) and bevacizumab (Avastin) for colorectal 
cancer. In addition, a growing pipeline of drug compounds targeting several members 
of the RTK family, such as EGFR, VEGFR, PDGFR, KIT and FLT3, are currently in 
clinical development.  
 
5.3  Caspase cleavage of RTKs 
Recent studies have implicated several members of the RTK family as 
proteolytic targets of caspases during apoptosis. Caspase cleavage of RTKs was found 
to be localized to the cytoplasmic domains of the receptors, frequently leading to the 
suppression of ligand-mediated trans-membrane signaling through the structural 
alteration of the kinase domains or the deletion of binding sites for downstream 
signaling proteins. Since the RTKs mediate downstream growth and survival signals 
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which are antagonistic to the apoptotic program, the cleavage of RTKs, in concert 
with other processes, appears to tip the balance of survival and death signals, leading 
to cellular commitment to apoptosis.  
Caspase cleavage of MET receptor at Asp1000 results in the inactivation of 
functional MET by loss of its signaling cytoplasmic part, with the concomitant 
appearance of membrane bound 100 kDa MET and a soluble intracellular 40 kDa 
MET (Tulasne et al., 2004; Foveau et al., 2007; Deheuninck et al., 2008). The 100 
kDa MET fragment prevents downstream survival activity by trapping the HGF 
ligand, while the 40 kDa MET fragment becomes ligand-independent and acquires 
pro-apoptotic activity. Interestingly, the 40 kDa fragment encompasses the entire 
MET kinase domain and kinase activity was shown to be necessary for pro-apoptotic 
function. As the 40 kDa fragment does not activate MAP kinase pathway, its pro-
apoptotic function was suggested to involve the kinase activity on pro-apoptotic 
effectors.  
ERBB2, a member of the EGFR family of RTKs, was shown paradoxically to 
function as a cell death effector activated by caspases. Full length ERBB2 protects 
cells from apoptosis by activating survival pathways while caspase cleavage was 
shown to unmask a previously unrecognized pro-apoptotic function of the receptor 
(Strohecker et al., 2008). It was demonstrated that the cytoplasmic tail of ERBB2 is 
cleaved at four sites (Asp1016, Asp1019, Asp1087 and Asp1087) by caspases. Cleavage of 
the receptor at Asp1016 or Asp1019 releases an intracellular carboxyl terminal 47 kDa 
fragment that is subsequently proteolyzed by caspases at Asp1125 to a predicted 25 
kDa product. Interestingly, both the 47 and 25 kDa products were found to induce 
apoptosis upon ectopic expression in cells and each of them possess a BH3-like 
domain similar to those found in the BH3-only pro-apoptotic members of the Bcl-2 
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family. EGFR was also shown to be cleaved Asp1012 and less efficiently at Asp1172 
(Bae et al., 2001; He et al., 2006). The cleavage at Asp1012 terminated downstream 
signaling through the removal of the binding sites for Cbl and Grb2 in cytoplasmic 
region of the receptor. However, unlike the ERBB2 receptor, no pro-apoptotic activity 
downstream of EGFR cleavage was reported. 
 The RET proto-oncogene was found to induce apoptosis in cells when 
expressed ectopically (Bordeaux et al., 2000). The induction of apoptosis was 
inhibited in the presence of its ligand, glial cell line derived neurotrophic factor 
(GDNF), suggesting RET behaves as a dependence receptor. The pro-apoptotic 
activity of RET was mediated through the cleavage of the receptor by caspases at 
Asp707 and Asp1017 - releasing a pro-apoptotic fragment whose activity was localized 
to the region bound by the two cleavage sites. Another dependence receptor, the 
anaplastic lymphoma kinase protein (ALK), was similarly shown to induce apoptosis 
in the absence of its cognate ligand (Mourali et al., 2008). The pro-apoptotic activity 
of unligated ALK is enhanced through the cleavage of the receptor by caspases at the 
juxtamembrane region (Asp1160). Cleavage of ALK exposes a pro-apoptotic region on 
the receptor which was mapped to region upstream of the cleavage site in the 
cytoplasmic domain of the receptor.  
As discussed in Chapter 1, the consequences of caspase cleavage of a 
signaling protein primarily results in the loss or gain of its function, depending on its 
role in the signaling pathway. However, as mentioned above, there is mounting 
evidence to suggest that RTK function is intimately regulated by caspase activity and 
the consequences of RTK cleavage are far more complex than simply the gain or loss 
of protein function. Also, given the pervasive role of RTKs in cell survival pathways 
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and their implications in diseases such as cancer, it is plausible that many other RTKs 
are hitherto undiscovered downstream targets of caspases. 
 
5.4 Prediction of caspase cleavage sites on RTKs 
The complete repertoire of RTKs - 52 members across 16 sub-families, as 
listed in the KEGG database (Kanehisa and Goto, 2000) - was retrieved from Uniprot 
database and predicted for caspase cleavage sites using the previously developed 
SVM method.  Protein sequences of RTKs were submitted to the CASVM server 
under default settings and results of prediction are listed in Table 5-1. All RTKs were 
predicted to possess caspase cleavage sites. Predicted cleavage sites were distributed 
throughout the length of the extracellular and intracellular regions of RTKs. About 
92% of all RTKs (48/52) possess cleavage sites on the intracellular region while about 
98% (51/52) contain extracellular cleavage sites. While predicted cleavage sites 
localize throughout the length of the receptors, certain trends could be observed in the 
distribution of predicted sites, implying functional significance downstream of 
caspase cleavage.  
A sizeable number of RTKs (~21%) were predicted for caspase cleavage sites 
at the juxtamembrane region on the cytoplasmic side of the receptors. It is 
conceivable that caspase cleavage at these sites will truncate the full length receptor 
into a membrane bound portion and an intracellular fragment. As such, receptor 
cleavage will likely lead to abrogation of downstream signaling and possibly 
interfering with normal RTK signaling through the trapping of ligands by the 
membrane-bound receptors (e.g. ALK cleavage). Significantly, recent studies suggest 
that an intracellular receptor fragment containing the tyrosine kinase domain may 
have downstream functional implications. Observations on high-throughput proteomic 
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screening of caspase substrates in Dix et al. (2008), reported that a substantial number 
of caspase substrates are cleaved into persistently stable, domain-containing 
fragments, and speculated that caspase-mediated proteolysis yields a class of effector 
protein fragments with novel functions. Moreover, as discussed earlier, cleavage of 
MET and ALK at their juxtamembrane region led to the release of pro-apoptotic 
intracellular receptor fragments. In both cases, the kinase domains were implicated in 
the pro-apoptotic response, though the exact mechanisms were unclear.  
On a related note, close to 80% (41/52) of all RTKs harbor caspase cleavage 
sites within the tyrosine kinase domain of the receptor. In particular, RTKs from the 
insulin receptor and FGF receptor sub-families are annotated with multiple cleavage 
sites within their tyrosine kinase domains. As these domains serve as key mediators of 
signal transduction for RTKs, structural alterations from caspase cleavage may lead to 
perturbations of downstream signaling. Interestingly, studies by Tikhomirov et al., 
(2005) indicate that proteolytic fragments bearing the motif “RLLGI” derived from 
the tyrosine kinase domains of EGFR, Erbb2, Erbb4, TrkA and VEGFR1 were able to 
induce apoptosis in cells. Indeed, caspase cleavage sites were predicted in the kinase 
domains of some of these receptors (EGFR; Asp770, Asp916, Erbb4; Asp878, Asp922 and 
VEGFR1; Asp958, Asp987 Asp1135), suggesting the possibility of caspase cleavage and 
release of pro-apoptotic intracellular kinase fragments. As the “RLLGI” motif is 
suggested to be prevalent among RTKs, it is possible that cleavage of the tyrosine 
kinase domains of several other RTKs could lead to the similar production of such 
pro-apoptotic fragments. Studies on Erbb2 cleavage have shown that the caspase 
cleavage produced pro-apoptotic intracellular fragments downstream of the kinase 
domain in the C-terminal region of the receptor. Cleavage of EGFR at a comparable 
location was shown but no pro-apoptotic consequences were reported. Interestingly, 
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the other members of the EGFR family, Erbb3 and Erbb4, were predicted to possess 
similarly located caspase cleavage sites, suggesting that these proteins could be 
caspase targets as well. 
Taken together, the presence and distribution of these predicted cleavage sites 
across the RTK family suggest that specific roles of caspase cleavage in regulating 
RTK function.  It is tempting to speculate a general phenomenon whereby caspase 
cleavage of RTKs leads to a molecular “life-death” switch which converts the pro-
survival protein to a pro-apoptotic one through the exposure and/or the release of pro-
apoptotic domains. Such reversal of protein function is similarly observed in the 
caspase cleavage of serine/threonine protein kinases, MEKK1 and MEKK4, which 
generated pro-apoptotic fragments upon cleavage at their kinase domains. Several 
other anti-apoptotic proteins such as Bcl-2 and Bcl-xl have been shown to be 
converted into pro-apoptotic molecules by caspase cleavage. The elegant integration 
of both anti- and pro- apoptotic functionalities on the same signaling protein is an 
uncommon but economical feature. Could it be reasoned that in an apoptotic cell, 
functionally disrupted cell survival and growth machineries would be further used for 
executing the stepwise destruction of the cell since their original function will no 
longer be needed? 
As most of the RTKs were predicted to harbor caspase cleavage sites on the 
extracellular domains, it is appealing to speculate if there are specific functional 
consequences of cleavage at these locations. While caspases have been shown to be 
involved in the cleavage of a myriad of substrates, most if not all, are localized in the 
cytoplasm. However, active caspases were found to be released into the extracellular 
environment during apoptosis (Hentze et al., 2001). In addition, work by Cowan and 
co-workers (2005) provided evidence for the localization of active caspase-2, caspase-
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3 and caspase-7 to the membrane surfaces of apoptotic smooth muscle cells. The 
caspases were thought to be bound to the cell surface receptors following release from 
the apoptotic cells and are involved in degrading the extracellular matrix as part of 
mediating the regression of advanced vascular disease. Clearly, future investigations 
on caspase activity in the extracellular environment will shed light on the possibility 
of RTK cleavage and downstream consequences. 
 
5.5 Conclusion 
In the chapter, a global scan of caspase cleavage sites on the family of receptor 
tyrosine kinases was conducted. The results suggest that RTK activity could be 
generally regulated by caspase cleavage. The presence of cleavage sites at the 
juxtamembrane and kinase domains of the RTKs indicate a likelihood of caspase-
mediated abrogation of RTK signaling and the production of pro-apoptotic 
intracellular fragments. Future biochemical and structural studies on caspase-
mediated RTK cleavage will be necessary to validate these issues. The results and 
discussion in this chapter is presented in the manuscript: Wee et al., (2008) Multi-
factor model for caspase degradome prediction
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Table 5-1 Global mapping of predicted caspase cleavage sites on receptor tyrosine kinases 
RTK Family RTKs  UNIPROT ID Predicted Caspase Cleavage Sites1 
EGF receptor EGFR P00533 321 458 587 770 916 1006 1009 1012 1083 1127 1152 1171       
 ERBB2 P04626 
277 326 382 639 1016 1019 1087 1125        
 ERBB3 P21860 
162 165 242 581 1010 1020 1327         
  ERBB4 Q15303 218 245 300 335 510 564 585 595 878 922 1012 1015 1018 1068 1241 
Insulin receptor INSR P06213 75 483 526 546 549 672 704 716 949 985 1145 1210 1259 1330 1344 
 INSRR P14616 
154 585 676 816 916 1101 1166 1207 1280       
 IGF1R P08069 
156 300 342 519 539 542 675 1121 1186 1235 1294 1306    
  ROS1 P08922 100 358 483 513 684 711 842 1202 1391 1853 2058 2062 2135 2247   
PDGF receptor PDGFRA P16234 215 244 287 422 568 733 763 846 902 919 1015 1024 1033 1074   
 PDGFRB P09619 
78 200 285 575 691 737 1091         
 CSF1R P07333 
51 63 269 741 746           
 KIT P10721 
439 479 768             
  FLT3 P36888 200 455 600 959                       
FGF receptor FGFR1 P11362 69 90 110 130 131 132 133 142 218 527 768 782       
 FGFR2 P21802 
75 126 135 136 138 506 521 530 785 794 795     
  FGFR3 P22607 
77 136 139 143 147 497 516 521 776 792      
  FGFR4 P22455 119 129 187 240 507 516 575 770 779             
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VEGF receptor VEGFR1 P17948 372 495 630 958 987 1135 1165 1168 1262             
 VEGFR3 P35916 
19 45 77 304 371 556 725 728 1130 1216 1274     
  VEGFR2 P35968 173 180 295 392 639 717 852 1141 1171 1174 1189 1259 1315     
HGF receptor MET P08581 174 231 352 824 1002 1231 1376 1380               
  MST1R Q04912 126 176 204 299 355 375 671 805 927 936 1030 1045 1235     
TRK receptor TRKA P04629 53 209 306                         
 TRKB Q16620 
173 277 349 406 409 424 476 579        
  TRKC Q16288 61 193 476 641                       
EPH receptor EPHA1 P21709 32 45 158 252 592 778 841                 
 EPHA2 P29317 
33 232 250 708            
 EPHA3 P29320 
17 34 159 282 299 531 708         
 EPHA4 P54764 
35 161 241 319 402 542          
 EPHA5 P54756 
65 187 190 348 430 995          
 EPHA6 Q9UF33 
57 163 243 440 970           
 EPHA7 Q15375 
37 314 404             
 EPHA8 P29322 
55 61 222 241 729 790 940         
 EPHB1 P54762 
24 118 138 528 771 840          
 EPHB2 P29323 
25 139 318 774 777           
 EPHB3 P54753 
138 333 785 786 918 935          
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 EPHB4 P54760 
226 242 836             
  EPHB6 O15197 63 139 142 271                       
AXL receptor AXL P30530 87 260 270 389 407 551 648 769 843             
 TYRO3 Q06418 
73 79 121 250 335 576 638 763        
   MERTK Q12866 309 402 610 706 827 843 900 983               
LTK receptor LTK P29376 87 193 335 340 348 557 705                 
  ALK Q9UM73 305 516 885 951 954 993 1017 1163 1311 1606           
TIE receptor TIE1 P35590 287 391 474 560 578 586 861 883               
  TIE2 Q02763 137 357 389 473 663 846 868 923               
ROR receptor ROR1 Q01973 167 387 395 580 591                     
   ROR2 Q01974 42 51 262 390 903                     
DDR receptor DDR1 Q08345 44 46 68 70 189 216 598 604 630 729           
  DDR2 Q16832 69 125 189 234 240                     
RET receptor RET P07949 43 264 267 547 567 707 797 1017 1031             
RYK receptor RYK P34925 258 351 554                         
MuSK receptor MUSK O15146 94 474 622 743 817                     
 
1 Positions of CASVM predicted cleavage sites on protein sequence of each RTK member are listed. Numbers indicate the positions of P1 (Asp) residues on protein 
sequences. All cleavage site positions are color coded; grey indicates location of cleavage site within the extracellular domain, blue indicates location within 
intracellular domain and darker blue indicates location within kinase domain (all kinase domains of RTKs are located in the intracellular domain of the receptor). 
Predicted cleavage sites corresponding to true experimentally verified cleavage sites on EGFR, ERBB2, MET, ALK and RET are underlined. 
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Chapter 6: Conclusion 
6.1 Summary of thesis 
Caspases belong to a unique class of proteases which distinctly recognize and 
cleave after specific tetrapeptide sequences on proteins. By cleaving a diverse set of 
substrates, caspases serve as critical effectors in important cellular processes such as 
inflammation, apoptosis, cell survival and differentiation. As protease function is 
invariably linked to the nature of its downstream targets, the characterization of the 
caspase degradome is an essential step for furthering the current knowledge of 
caspase biology in health and disease.  
In this thesis, the primary objective is the elucidation of the caspase 
degradome through the identification of known and hitherto undiscovered caspase 
substrates. Instead of utilizing experimental methods, an unconventional method 
using computational prediction was adopted. The framework for computational 
prediction of caspase substrates began with the construction of clean and reliable 
datasets on caspase substrates from published literature and biomedical databases. 
The outcome of this process was the establishment of a web-accessible database for 
caspase substrates (available at www.casbase.org/casvm/squery/index.html) and 
downloadable datasets containing experimentally-verified caspase substrates and 
associated annotations. Next, a computational prediction model based on the support 
vector machines (SVM) algorithm was developed for predicting caspase cleavage 
sites. By accounting for the preferential tetrapeptide cleavage site sequences and 
upstream and downstream flanking sequences, the model was shown to be 
comparable, if not superior to existing computational tools. Additionally, CASVM - a 
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web server integrating the SVM method for predicting caspase cleavage sites - was 
implemented and is available at www.casbase.org/casvm/index.html. 
While the presence of cleavage sites is required for substrate cleavage, it is not 
sufficient for robust prediction of substrates on its own. Other factors such as the 
exposure of cleavage sites to solvent, local secondary structures, substrate localization 
and other post-translational modifications may be important as well. Consequently, 
the computational prediction model was extended to account for other structural 
features such as secondary structures and solvent exposure. Analyses of caspase 
substrates concluded that cleavage sites preferentially locate in regions on the 
substrates which are unstructured and solvent exposed. Accordingly, a two-step model 
for predicting caspase substrates was developed. In the first step, a set of potential 
caspase cleavage sites is predicted by the SVM model (using CASVM). In the second 
step, a score-based system quantifies predicted cleavage sites for their propensities to 
locate in solvent exposed and unstructured regions, and selects for those which are 
above a user-defined cut-off score. The two-step model was shown to improve the 
accuracy of substrate identification over standalone prediction of caspase cleavage 
sites by reducing proportion of false positives.  
To explore the application of computational prediction for elucidating the 
caspase degradome, the receptor tyrosine kinase (RTK) family was predicted for 
potential caspase substrates. The RTKs belong to a class of membrane receptors 
which play critical roles in cell survival, proliferation and differentiation, and have 
been implicated in several human cancers. A total of 52 RTKs across 16 sub-families 
were predicted for the presence of caspase cleavage sites using the SVM method 
developed here. The predicted results showed a wide spread presence of caspase 
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cleavage sites among the RTKs. The observed patterns of cleavage site locations at 
the juxtamembrane and tyrosine kinase domains of the RTKs indicate a likelihood of 
caspase-mediated abrogation of RTK signalling and the production of pro-apoptotic 
intracellular fragments. The caspase-mediated cleavage of RTKs could be a novel 
mode of regulation for these receptors and possibly implicate them as molecular “life-
death” switches. 
 
6.2 Future directions 
The prediction of caspase substrates serves as a complementary tool to 
experimental methods for the elucidation of the caspase degradome. While 
experimental methods are necessary for validation of true substrates, it is often 
cumbersome and expensive. On the other hand, computational prediction, much like 
weather forecasting, provides a peek into the likelihood of substrate cleavage without 
having to get the hands dirty - literally. The price of such convenience is accuracy. It 
is evident, then, that future work on this domain will be driven by the question: what 
more can be done to improve prediction accuracy? 
As discussed in Chapter 4, a robust model for predicting caspase substrates – 
or any other protease substrates – will be dependent on integrating meaningful, non-
correlated factors affecting substrate cleavage. The primary determinant of caspase 
cleavage remains the presence of distinctive tetrapeptide cleavage sites. Besides 
accounting for these specificities and the neighbouring flanking sequence tendencies, 
other structural factors such as the local secondary structures and degree of exposure 
to solvent are important. These factors have been carefully considered and are 
integrated into the model for two-step prediction of caspase substrates (as mentioned 
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in Chapter 4). However, as the inputs for these factors rely on results from secondary 
structures and solvent accessibilities prediction, there are still degrees of uncertainty. 
Clearly, future development of better secondary structure and solvent accessibilities 
prediction tools and algorithms, as well as the elucidation of three-dimensional 
structural data on caspase substrates, will be helpful for efforts here. 
 Beyond the cleavage sites, it has also been suggested other structural features 
on the substrate are important for cleavage. As discussed in Chapter 4, exosite-
interaction sites distal from the enzyme active site could mediate substrate cleavage 
and may be responsible for non-canonical caspase substrate cleavage. As exosites 
were shown to be involved in other protease-substrate systems as well, it may be 
helpful to account for such features in the prediction model.  In addition, recent 
studies have proposed that certain post-translational modifications on the substrate 
could mediate caspase cleavage. Serine phosphorylation of residues at or close to the 
substrate cleavage site was found to be inhibitory to substrate cleavage (Tözsér et al., 
2003). Indeed, the phosphorylation of tau - a protein implicated in the formation of 
neuronal tangles in Alzheimer's disease - at Ser422, was shown to inhibit cleavage by 
caspases in vivo (Guillozet-Bongaarts et al., 2006). More recently, SATB1, a protein 
associated with the matrix attachment regions, was shown to exhibit enhanced 
cleavage by caspases when the small-ubiquitin modifier (SUMO) protein was over-
expressed in cells – suggesting that sumolyation may yet be another mode of 
regulation for caspase cleavage (Tan et al., 2008).  
The involvement of caspases in seemingly unrelated and perhaps antagonistic 
processes such as cell proliferation and apoptosis argues for an even more complex 
blend of factors regulating substrate cleavage. If caspases are activated during mitosis, 
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how could caspase cleavage be restricted to those cell cycle regulators, while leaving 
other critical proteins intact? As discussed in Fischer et al. (2003), when caspases 
were activated and the cell cycle regulator Wee1 was cleaved after mitogenic T-cell 
stimulation, neither DNA replication factor RFC140 nor ICAD were cleaved in 
proliferating T cells. Cleavage of RFC140 and ICAD would lead to inhibition of DNA 
replication and fragmentation of genomic DNA, events that are not compatible with 
cell proliferation. Perhaps the answer could lie in a specific sub-cellular 
compartmentalization of caspases, the existence of scaffold proteins or a different 
accessibility of cleavable substrates. Other factors such as the coordinated expression 
of anti-apoptotic molecules or overall level of caspase activity may play a role in the 
selectivity of caspase cleavage. For instance, it was reported that the partial cleavage 
of Ras-GAP, a GTPase in the Ras signaling pathway, owing to low caspase activity 
first generates an N-terminal fragment that is anti-apoptotic by activating the PI3K 
pathway. Increased caspase levels, in contrast, result in the further cleavage of Ras-
GAP into two proapoptotic fragments.   
Future progress in computational prediction of caspase substrates, and 
possibly for any other protease-substrate system, will clearly hinge on the careful 
aggregation and integration of factors for substrate cleavage. While it is likely that 
certain fundamental elements of proteolysis are universally applicable across all 
protease-substrate systems, the intricacies and idiosyncrasies of each system – as 
clearly shown for the caspase substrates – necessitate deeper analysis and thought for 
building robust prediction models. It is also certain that such efforts will be greatly 
assisted as more data on caspase substrates are made available through experimental 
efforts. At the time of this writing, there are possibly close to 800 caspase substrates 
98 
 
experimentally elucidated - a clear jump in numbers when compared to those reported 
by Fischer et al. in 2003. A large part of this advance is contributed from improved 
high-throughput screening of caspase substrates by Mahrus et al. (2008) and Dix et al. 
(2008). Continual advancements in high-throughput screening of protease substrates 
will play an increasing role in the future for identifying novel substrates and protease-





















6.3 Key contributions 
The original work in this thesis makes several important contributions to the 
fields of bioinformatics and caspase biology: 
• Creation of expertly-curated datasets of caspase substrates. The 
datasets comprise of cleavage sites sequences and location, and other 
data related to the substrates. These datasets can be readily 
manipulated for use in information systems or for the development and 
testing of prediction algorithms. 
• Creation of a relational database for caspase substrates (available at 
www.casbase.org/squery/index.html). The database allows users to 
retrieve data on caspase substrates using multiple query modes and 
provides viewing of useful annotations related to substrate cleavage. 
• Development of a support vector machines based method for 
predicting caspase cleavage sites on protein sequences. The method 
was shown to perform comparably, if not better than existing 
computational methods. Unlike other methods, the method utilizes 
additional information from sequences upstream and downstream of 
the tetrapeptide cleavage sites. The method was integrated onto a web 
server which allows users to scan their sequences for potential caspase 
cleavage sites (available at www.casbase.org/casvm/index.html).  
• Analyses on the structural characteristics of cleavage sites on caspase 
substrates were conducted. Caspase cleavage sites were found to 




• A two-step approach for predicting caspase substrates was developed. 
The algorithm comprises of first predicting the protein sequence for 
caspase cleavage sites followed by a filtering step where less 
structurally favourable cleavage sites were eliminated according to a 
user-defined cut-off score. The method proved to be helpful for 
improving the overall accuracy of predicting caspase substrates by 
reducing the proportion of false positives. 
• A global prediction of caspase cleavage sites across all proteins in the 
human proteome was made. The receptor tyrosine kinase (RTK) family 
was analysed in detail for the occurrences of cleavage sites and 
consequences of caspase cleavage. Based on the analyses, the RTKs 
are suggested to be commonly regulated by caspase cleavage, with 
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Table A-1 Fischer Dataset 
Caspase Substrate Uniprot ID Cleavage_sites1 
Apaf-1 O14727 SVTD (271) and a second unknown site 
Bad Q92934 Human: EQED (14) Mouse: SATD (61) 
Bax Q07812 FIQD (33) 
Bcl-2 P10415 DAGD (34) 
Bcl-xL Q07817 HLAD (61), SSLD (76) 
Bid P55957 LQTD (59) 
c-FLIP O15519 LEVD (376) 
c-IAP1 Q13490 ENAD (372) 
XIAP P98170 SESD (242) 
APC P25054 DNID (777) 
CALM O60641 Not reported 
Cas Q63767 DVPD (416), DSPD (748) 
Beta-Catenin P35222 SYLD (32), ADID (83), TQFD (115), YPVD (751), DLMD(764) 
Gamma-Catenin Q86W21 Not reported 
Desmoglein-3 P32926 DYAD (781) and additional unknown sites 
Desmocollin 3 Q14574 Not reported 
Desmoplakin P15924 Not reported 
E-cadherin P12830 DTRD (750) 
N-cadherin P19022 Not reported 
P-cadherin P22223 Putative site: ETAD (695) 
FAK Q05397 DQTD (772) 
HEF1 Q14511 DLVD (363), DDYD (630) 
Connexin 45.6 P36381 DEVE (367) 
Paxillin P49023 Early: NPQD (102), SQ LD (301) Late: DDLD (5), SELD (146), FPAD (165), SLLD (222) 
Plakophilin-1 Q13835 Not reported 
alpha-actin P04270 Not reported 
beta-actin P60709 ELPD (244) 
alpha-actinin P12814 Not reported 
alpha-adducin P35611 DDSD (633) 
CD-IC O88485 DSGD (99) and an additional unknown site 
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Cortactin Q14247 Not reported 
Filamin P21333 Not reported 
alpha-II-fodrin Q13813  DETD (1185)  
beta-II-fodrin Q01082 DEVD (1457) 
Gas2 O43903 SRVD (37) 
Gelsolin P06396 DQTD (403) 
HIP-55 Q6IAI8 EHID (361) 
HS1 P14317 Not reported 
Cytokeratin 14 P02533  Not reported 
Cytokeratin 17 Q04695 VEMD (241), EVQD (416) 
Cytokeratin 18 P05783 VEVD(238) -caspase-3, caspase-6 and caspase-7; DALD(397)- caspase-3 and caspase-7 
Cytokeratin 19 P08727 Not reported 
MHC P35579 Not reported 
vMLC P08590 DFVE (134) 
p150-Glued (dynactin) Q14203 Not reported 
Plectin Q15149 ILRD (2395) 
beta-II spectrin Q01082 DSLD (1478), DEVD (1457), ETVD (2146) 
Tau P10636 DMVD (421) 
Troponin T P45379 VDFD (96) 
alpha-tubulin P05209 LEKD (431) 
Vimentin P08670 DSVD (85)-caspase-3, caspase-7; IDVD (259)-caspase-6, caspase-9; TNLD (429) 
Emerin O08579 Not reported 
LBR Q14739 Not reported 
Lamin A P02545 VEID (230) 
Lamin B1 P20700 VEVD (231) 
Lamin C P02545-2 VEID (230) 
LAP2-alpha P42166 Putative sites: KRID (413), EERD (441), SQHD (483) 
Nup153 P49790 DITD (343) 
Nup214 P35658 Not reported 
RanBP2/Nup358 P49792 Not reported 
SAF-A Q00839 SALD (100) 
SATB1 Q01826 VEMD (254) 
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Tpr P12270 Putative sites: DSQD (1892), DGTD (1999), DDED (2117), DDGD (2250), DESD (2285) 
p28BAP31 P51572 AAVD (164) 
Golgin-160 Q08378 ESPD (59), CSTD (139), SEVT(311) 
GRASP65 Q91X51 SLLD (320), SFPD (375), TLPD (393) 
Kinectin Q86UP2 Not reported 
c-Abl P00519 Putative sites: DTTD (546), DTAD (655) 
Bcr-Abl NA Putative sites: DTTD (546), DTAD (655) 
Cdc6 Q99741 LVRD (99 ), SEVD (442) 
CDC27 P30260 Not reported 
Cyclin A P47827 DEPD (90) 
Cyclin E P24864 Not reported 
MDM2/HDM2 Q00987 DVPD (361) 
MDMX O15151 DVPD (361) 
NuMA Q14980 DSLD (1712) 
p21Waf1 P38936 DHVD (112) 
p27Kip1 P46527 DPSD (139), ESQD (108) 
PITSLRE P21127-2 YVPD (391) 
Prothymosin-alpha P06454 Three overlapping sites at the C-terminus: DDEDDDVD(101) 
Rb P06400 DEAD (886) 
Wee1 P30291 Not reported 
Acinus Q9UKV3 DELD (1093) 
ATM Q13315 DYPD (863) 
BLM P54132 TEVD (415) 
BRCA-1 P38398 DLLD (1154) 
DNA-PKCs P78527 DEVD (2713) 
ICAD O00273 DETD (117), DAVD (224) 
Helicard Q8R5F7 DNTD (208), SCTD (251) 
MCM3 P25205 Not reported 
PARG Q86W56 DEID (256), MDVD (307) 
PARP-1 P09874 DEVD (214) 
PARP-2 O88554 LQMD (186) 
Pol e catalytic subunit 
A Q07864 DQLD (189), DMED (1185) 
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RAD21 O60216 DSPD (279) 
RAD51 Q06609 DVLD (187) 
RFC140 P35251 DEVD (722) 
Topo I P11387 PEDD (123)-caspase-6; DDVD (146), EEED (170) -caspase-3 
Topo II-alpha P11388 Not reported 
XRCC4 Q13426 Not reported 
AP-2 alpha P05549 DRHD (19) 
CREB P16220 Putative site: ILND (140) or LSSD (144) 
c-Rel Q04864 Not reported 
GAL4 P04386 Unknown C-terminal cleavage sites 
GATA-1 P15976 EGLD (42), EDLD (125), LSPD(144) 
HSF Q00613 Not reported 
hTAF(II)80 d P49848 Not reported 
IkBa P25963 DRHD (32) 
LEDGF O75475 EVPD (30), WEID (85), DAQD(486) 
Max P61244 IEVE (10), SAFD (135) 
MEF2A Q02078 SSYD (466) 
MEF2C Q06413 SSYD (422) 
MEF2D Q14814 LTED (288), DHLD(291) 
NF-kB p50 P19838 Not reported 
NF-kB p65 Q04206 VFTD (465) 
NRF2 Q16236 TEVD (208), EELD (366) 
PML-RAR alpha Q15156 PHLD (523) 
RAR alpha P10276 Not reported 
Relish Q94527 Not reported 
Sp1 P08047 NSPD (590) 
SREBP-1 P36956 Not reported 
SREBP-2 Q12772  DEPD (468) 
SRF P11831 Not reported 
STAT1 P42224 MELD (694) 
BTF3 P20290 Putative site: QSVD (175) 
hnRNPs A0 Q31351 Not reported 
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hnRNP A2/B1 P22626 KLTD (49), VMRD (55), AEVD (76), putative sites. 
hnRNP A3 P51991 Not reported 
hnRNP C1 P07910-2 NKTD (10), EGED (295), DDRD (298), GEDD (305), putative sites. 
hnRNP C2 P07910 NKTD (10), EGED (295), DDRD (298), GEDD (305), putative sites. 
hnRNP I P26599 IVPD (7), LKTD (139), AAVD (172). 
hnRNP K P61978 Not reported 
hnRNP R O43390 RAID (66) and DYYD (472) or KESD (87) and DYHD (481), putative sites 
KHSRP Q92945 Putative sites: IRKD (72), AFAD (76), IGGD (91), STPD (102), QLED (114), EDGD (116), SQGD (128) 
NONO/ p54nrb Q15233 Putative site: MMPD (421) 
NS1-associated 
protein1 O60506 Not reported 
Nucleolin P19338 Putative sites: TEID (455), and AMED (629) or GEID (633) 
RHA Q08211 EEVD (167) 
SFRS1 Q07955 Putative sites: DLKD (139), CYAD (151), VYRD (155), RKLD (176) 
SFRS9 Q13242 Putative site: GWAD (6) 
SRPK1 Q96SB4 Not reported 
SRPK2 P78362 Not reported 
SS-B/La-autoantigen P05455 DEHD (371) or DEHD (374) 
U1-70-kDa snRNP P08621 DGPD (341) 
60S acidic ribosomal 
protein P0 P05388 Putative sites: PRED (5), EESD (308), SDED (310) 
DAP5 P78344 DETD (792) 
eIF2a Update in progress AEVD (301) or DGDD (304) 
eIF3 Update in progress DLAD (242), DYED (256) 
eIF4B Update in progress DETD (45) 
eIF4E-BP1 Update in progress VLGD (25) 
eIF4GI Update in progress DLLD (492), DRLD (1136) 
eIF4GII Update in progress Not reported 
NAC-alpha Q13765 Not reported 
PABP4 Q13310 Not reported 
SRP72 O76094 SELD (614) 
pro-IL-1b P01584 YVHD (116) 
pro-IL-16 Q14005 SSTD (510) 
pro-IL-18 Q14116 LESD (36) 
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pro-EMAP-II P31230 ASTD (144)  
DCC P43146 LSVD (1290) 
EGF-R P00533 Putative sites: DEED (1006), DMDD (1009) 
ErbB-2 P04626 SETD (1125) 
GluR1 Update in progress Asp 865 
GluR2 Update in progress update in progress 
GluR3 Update in progress update in progress 
GluR4 Update in progress update in progress 
RET P07949 VSVD (707), DYLD (1017) 
TCR zeta P20963 GLLD (28) or YLLD (36), and DTYD (153) 
TNF-R1 P19438 GELE (260) 
GrpL/Gads O75791 DIND (241) 
TRAF1 Q13077 LEVD (163) 
TRAF3 Q13114 EEAD (348), ESVD (368) 
TXBP151 Q13311 Not reported 
ETK/BMX P51813 DFPD (242) and a second unknown site 
Fyn P06241 EERD (19) 
Lyn P07948 DGVD (18) 
Src P12931 Not reported 
AKT P31749 TVAD (108), EEMD (119), ECVD (462) 
CaMK IIa Q9UQM7 Not reported 
CaMK IV Q16566 YWID (35), PAPD (178) 
CaMKK Q9BQH3 Not reported 
CaMKLK Update in progress DEND (62),  
CaMKLK Update in progress  putative DEND site at 369 
CaMKLK Update in progress  putative DEND site at 369 
HPK-1 Q92918 DDVD (385) 
MASK Q9P289 DESD (305) 
MEK Q02750 Not reported 
MEKK1 P53349  DTVD (874)  
Mst1 Q13043 DEMD (326) 
Mst2 Q13188 DELD (322) 
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Mst3 Q9Y6E0 AETD (325) 
PAK2 Q13177 SHVD (212) 
PKC delta Q05655 DMQD (329) 
PKC epsilon Q02156 SSPD (383),  
PKC epsilon P16054 Mouse: SATD (383) 
PKC eta P24723 Unknown site in or upstream of the V3 region 
PKC mu Q15139 CQND (378) 
PKC theta Q04759 DEVD (354) 
PKC zeta Q05513 EETD (210), DGVD (239) 
PKR P19525 DLPD (251) 
PRK1 Q16512 Not reported 
PRK2 Q16513 DITD (117) 
Raf-1 P04049 Not reported 
RIP-1 Q13546 LQLD (324) 
ROCK-1 Q13464 DETD (1113) 
SPAK Q9UEW8 DEMD (392)  
SPAK O88506 rat: DEMD (398)  
SPAK Q9Z1W9 Mouse: DEMD (402) 
p70S6K P23443 Not reported 
FTase P49354 VSLD (59) 
GGTase I P49354 VSLD (59) 
tTG P21980 Not reported 
Calpastatin P20810 ALDD (137), LSSD (203), ALAD (404) 
Cbl P22681 Not reported 
Cbl-b Q13191 Not reported 
Nedd4 P46934 DQPD (206) 
PA28-gamma P61289 DGLD (80) 
PAI-2 P05120 Not reported 
UFD2 O95155 MDID (109), VDVD (123) 
Cdc42 P60953 DLRD (121) 
D4-GDI P52566 DELD (19) 
Rabaptin-5 Q15276 DESD (438) 
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Rac P15154 DLRD (121) 
Ran-GAP1 P46060 Not reported 
Ras-GAP P20936 DEGD (157), DTVD (459) 
TIAM1 Q13009 DETD (993) 
Vav-1 P15498 DQID (150), DLYD (161) 
CCT-alpha P49585 TEED (28) 
IP3 receptor-1 P11881  DEVD (1892) 
IP3 receptor-2 Q9Z329 Not reported 
PIP5K-I alpha Q99756 DIPD (279) 
PDE4A5 O89084  DAVD (72) 
PDE5A1 O76074 Not reported 
PDE6 P16499 Putative site: DFVD (167) 
PDE10A2 Q9ULW9  DLFD (333) 
PDE10A3 Q9QYJ6 DLFD (315), 
PMCA-2 Q01814 Putative site: EEID (1072) 
PMCA-4 P23634 DEID (1080) 
iPLA2 O60733 DVTD (183) 
cPLA2a P47712 DELD (336) 
PLC-g1 P19174 AEPD (770) 
Androgen receptor P10275 DEDD (155) 
APLP1 P51693 VEVD (620) 
APP P05067 VEVD (739) 
Ataxin-3 P54252 Putative sites: LISD (145), DLPD (171), LDED (225), DEED (228) 
Atrophin-1 P54259 DSLD (109) 
Calsenilin Q9Y2W7 DSSD (64) 
Huntingtin P42858 DSVD (513), DEED (530), IVLD (586) 
Parkin O60260 LHTD (126) 
Presenilin-1 P49768 AQRD (345) 
Presenilin-2 P49810 DSYD (329) 
CrmA P07385 LVAD (303) 
M2(influenza A) P21430 DVDD (88) 
NP(influenza A and B) P18277 Influenza A: METD (16), Influenza B: MDID (7), SEAD(61) 
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FEM-1 P17221 ELLD (320) 
FKBP46 Q26486 Not reported 
GCL P48506 AVVD (499) 
Hsp90 alpha P07900 DEED (259) 
Hsp90 beta P08238 DEED (259) 
PDC-E2 P10515 Not reported 
 
1 Cleavage sites are reported as tetrapeptides in the order: P4-P3-P2-P1. Numbers in parentheses 














Table A-2 Post-Fischer Dataset 
Caspase Substrate Uniprot ID Cleavage Site(s)1 
SATB1 Q01826 VEMD (254) 
p73 O15350 TSPD (10) and at least one other cleavage site 
BAG3 O95817 Not reported 
HAX-1 O00165 TLRD (127) 
HuR Q15717 MGVD (226) 
Nogo-B Q9JK11 SSTD (15) 
CD74 P04441 DQRD(6) 
PDI P07237 VAFD (383) 
BNIP-2 Q12982 Putative: IDLD (84), DGLD (86) 
BNIP-xl Q58A63 Putative: VETD(2131), DNSD(2134) 
IKK1 O15111 Not reported 
NEMO Q9Y6k9 RIED (355) 
TDP-43 Q13148 Putative: DEND (13), DETD (89), DVMD (219) 
EAAT2 P43006 DTID (504) 
Matrin 3 P43243 DETD (680) 
Mcl-1 Q07820 EELD (127), TSTD (157),  
Neurocresin Q789F1 DESD (358) 
GRASP65 O35254 SLLD (319), SFPD (374), TLPD (392) 
Human homolog of Ufd2p O95155 VDVD (123) MDID (109)  
NHE1 Na+/K+ exchanger P19634 DEDD (758) 
CEACAM1-L P31809 DQRD (460) 
Tensin Q04205 DYPD (1237)  
14-3-3 P62258 MQGD (238) 
Sm-F P62306 EEED (81) 
PTEN P60484 QEID (301), DVSD (371),NEPD (375), DTTD (384) 
α2-spectrin Q13813 DETD (1185) 
JNK 1 β2  P45983-4   SDTD (413) 
JNK 2 β2 P45984-4 SDTD (410) 
SCL/Tal-1 P17542 EITD (180), SSLD (296) 
SRF-N P11831 EETD (245), SESD (254) 
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Rad9 Q6FI29  Putative: EEAD (187), SDTD (269) and DDID (304) 
Cdc6 Q99741 SEVD (442) 
Livin Q96CA5 DHVD (52) 
AP-1 complex (β-adaptin) O35643 DLFD (701), DQPD (620) 
AP-1 complex (γ-adaptin) P22892 DMTD (746), DLLD (629) 
BimEL O43521 SECD(13) 
BAT3 P46379 DEQD (1001) 
Syntaxin 5 Q08851 DEQD (209) 
Her-2 P04626 SETD (1125) DVFD (1087) 
ERK2/MAPK P63086 ELDD (334) 
NDUSF1 P28331 DVMD (255) 
Histone deacetylase 4 P56524 DVTD (289) 
p23 co-chaperone Q15185 PEVD (142), DGAD(145) 
MET  P16056 ESVD (1000) 
Notch1 P46531 DQTD (1840), DCMD (1874), EEED (1906), DHMD (2095), CLLD (2193) 
DIAP1 Q24306 DQVD (20), VQPE (205) 
CTEN Q8IZW8 DSTD (570) 
LIM-Kinase 1 P53667 DEID (240) 
p65 Q04206 DCRD (97) 
Ca2+ ATPase (isoform 4b) P23634 DEID (1080) 
Twist P26687 DELD (173) 
Claspin Q9HAW4 DEYD (1072) 
MITF O75030-9 DLTD (345) 
 
1 Cleavage sites are reported as tetrapeptides in the order: P4-P3-P2-P1. Numbers in parentheses 


















Table B-1 Dataset of caspase substrate cleavage sites (for cross-validation and SVM training). 
 
Caspase Substrate Uniprot Accession ID Cleavage Site
1 P1 Position
2 
    
Acinus Q9UKV3 DELD 1093 
Akt P31749 TVAD 108 
  EEMD 119 
  ECVD 462 
α-Adducin P35611 DDSD 633 
α-II-Fodrin Q13813 DETD 1185 
Androgen Receptor P10275 DEDD 155 
AP-2 α P05549 DRHD 19 
Apaf-1 O14727 SVTD 271 
APC P25054 DNID 777 
Ataxin-3 P54252 LISD 145 
  LDED 225 
ATM Q13315 DYPD 863 
Bad Q92934 EQED 14 
Bax Q07812 FIQD 33 
Bcl-2 P10415 DAGD 34 
Bcl-xL Q07817 HLAD 61 
  SSLD 76 
β-Actin P60709 ELPD 244 
β-Catenin P35222 TQFD 115 
  ADID 83 
  SYLD 32 
  YPVD 751 
  DLMD 764 
β-II Spectrin Q01082 ETVD 2146 
  DEVD 1457 
Bid P55957 LQTD 60 
BLM P54132 TEVD 415 
BRCA-1 P38398 DLLD 1155 
BTF3 P20290 QSVD 175 
c-Abl P00519 DTTD 546 
  DTAD 655 
Calcineurin P48452 DGFD 385 
Calsenilin Q9Y2W7 DSSD 64 
Cas Q63767 DSPD 748 
  DVPD 416 
CCT-α P49585 TEED 28 
Cdc42 P60953 DLRD 121 
Cdc6 Q99741 LVFD 99 
CD-IC O14576 DSGD 99 
c-FLIP O15519 LEVD 376 
c-IAP1 Q13490 ENAD 372 
Connexin 45.6 P36383 DEVE 367 
CREB P16220 ILND 140 
  LSSD 144 
CrmA P07385 LVAD 303 
Cyclin A2 P18606 DEPD 90 
Cytokeratin 18 P05783 DALD 396 
  VEVD 237 
DCC P43146 LSVD 1290 
Desmoglein-3 P32926 DYAD 781 
E-cadherin P12830 DTRD 750 
EGF-R P00533 DMDD 1009 
  DEED 1006 
eIF2α P05198 DGDD 303  
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Caspase Substrate Uniprot Accession ID Cleavage Site
1 P1 Position
2 
eIF3 O75822 DLAD 242 
eIF4E-BP1 Q13541 VLGD 24 
eIF4GI Q04637 DRLD 1176 
Erb-2 P04626 SETD 1125 
ETK/BMX P51813 DFPD 242 
FAK Q05397 DQTD 772 
FEM-1 P17221 ELLD 320 
Ftase P49354 VSLD 59 
γHSV68 Bcl-2 homolog P89884 DCVD 31 
Gas2 O43903 SRVD 278 
GATA-1 P15976 LSPD 144 
  EDLD 125 
  EGLD 42 
GCL P48506 AVVD 498 
Golgin 160 Q08378 ESPD 59 
  SEVD 311 
  CSTD 139 
GRASP65 Q91X51 TLPD 392 
  SFPD 374 
GrpL/Gads O75791 DIND 241 
HEF1 Q14511 DLVD 363 
  DDYD 630 
Helicad Q8R5F7 DNTD 208 
  SCTD 251 
HIP-55 Q6IAI8 EHID 361 
hnRNP A2/B1 P22626 VMRD 55 
  AEVD 76 
  KLTD 49 
hnRNP C1/C2 P07910 EGED 295 
hnRNP I P26599 LKTD 139 
hnRNP R O43390 DYHD 481 
  KESD 87 
  DYYD 472 
  RAID 66 
HPK-1 Q92918 DDVD 385 
Huntingtin P42858 IVLD 586 
ICAD O00273 DAVD 224 
iPLA2 O60733 DVTD 183 
KHSRP Q92945 QLED 114 
  EDGD 116 
  IGGD 91 
  AFAD 76 
  SQGD 128 
  IRKD 72 
  STPD 102 
Lamin A P02545 VEID 230 
LAP2-α P42166 SQHD 482 
  EERD 440 
  KRID 412 
LEDGF O75475 DAQD 486 
  WEID 85 
  EVPD 30 
Lyn P07948 DGVD 17 
Max P61244 SAFD 135 
Mcl-1 Q07820 EELD 127 
  TSTD 157 
 





Caspase Substrate Uniprot Accession ID Cleavage Site
1 P1 Position
2 
MEF2D Q14814 LTED 288 
MEKK1 P53349 DTVD 874 
Mst1 Q13043 DEMD 326 
Mst3 Q9Y6E0-2 AETD 313 
Nedd4 P46935 DQPD 237 
NF-kappa-B p65 Q04206 VFTD 465 
NONO/p54nrb Q15233 MMPD 421 
NP Q701N7 METD 16 
Nucleolin P19338 AMED 628 
  TEID 454 
  GEID 632 
NuMA Q14980 DSLD 1726 
Nup153 P49790 DITD 349 
p21Waf P38936 DHVD 112 
p27Kip1 P46527 DPSD 139 
  ESQD 108 
p28BAP31 P51572 AAVD 163 
PA28γ P61289 DGLD 80 
PAK2 Q13177 SHVD 212 
PARG Q86W56 MDVD 307 
  DEID 256 
Parkin O60260 LHTD 126 
PARP-2 O88554 LQMD 187 
Paxillin Q8VI37 SELD 146 
  SQLD 301 
  SLLD 222 
  FPAD 165 
  NTQD 102 
PDE10A2 Q9QYJ6 DLFD 315 
PDE6 P16499 DFVD 166 
PIP5K-1α Q99756 DIPD 279 
PKCδ Q05655 DMQD 329 
PKCε Q02156 SSPD 383 
PKCµ Q15139 CQND 378 
PKCζ Q05513 DGMD 239 
  EETD 210 
PKR P19525 DLPD 251 
PLCγ1 P19174 AEPD 770 
Plectin Q15149 ILRD 2395 
Presenilin-1 P49768 AQRD 345 
Presenilin-2 P49810 DSYD 329 
pro-EMAP-II P31230 ASTD 144 
pro-IL-1β P01584 YVHD 116 
pro-IL-16 Q14005 SSTD 510 
pro-IL-18 Q14116 LESD 36 
Rad51 Q06609 DVLD 187 
Ras-GAP P20936 DEGD 157 
Rb P06400 DEAD 886 
RET P07949 VSVD 707 
  DYLD 1017 
RHA Q08211 EEVD 167 
SATB1 Q01826 VEMD 254 
SFRS1 Q07955 VYRD 154 
  DLKD 138 
  RKLD 175 
  CYAD 150 






Accession ID Cleavage Site
1 P1 Position
2 
Sp1 P08047 NSPD 590 
SS-B/La autoantigen P05455 DEHD 371 
STAT1 P42224 MELD 694 
TCRζ P20963 YLLD 36 
  GLLD 28 
  DTYD 154 
TNF-R1 P19438 GELE 260 
Topo I P11387 PEDD  123 
  EEED 170 
  DDAD 146 
Tpr P12270 DESD 2285 
  DSQD 1892 
  DDGD 2250 
  DDED 2117 
TRAF3 Q13114 ESVD 368 
  EEAD 348 
U1-70-kDa snRNP P08621 DGPD 341 
UFD2 O95155 VDVD 123 
  MDID 109 
Vav-1 P15498 DQID 150 
  DLYD 161 
Vimentin P08670 TNLD 428 
  IDVD 258 
  DSVD 84 
vMLC P08590 DFVE 134 
XIAP P98170 SESD 242 
    
 
1 Cleavage sites are reported as tetrapeptides in the order: P4-P3-P2-P1. Except for DEVE (from connexin 45.6), 
GELE (fromTNF-R1) and DFVE (from vMLC), all cleavage sites have an Asp (D) in the P1 position. 












Table B-2 Dataset of caspase substrate cleavage sites (for independent out-of-sample testing).  
 
Caspase Substrate Uniprot Accession ID Cleavage Site
1 P1 Position
2 
    
14-3-3 P62258 MQGD 238 
AP-1 complex (γ-adaptin) P22892 DMTD 746 
BAT3 P46379 DEQD 1001 
CEACAM1-L P31809 DQRD 460 
Claspin Q9HAW4 DEYD 1072 
CTEN Q8IZW8 DSTD 570 
DIAP1 Q24306 DQVD 20 
  VQPE 205 
ERK2/MAPK P63086 ELDD 334 
Her-2 P04626 DVFD 1087 
JNK 1 β2  P45983-4   SDTD 413 
MITF O75030-9 DLTD 345 
NDUSF1 (p75 subunit of complex1) P28331 DVMD 255 
Notch1 P46531 CLLD 2193 
  DCMD 1874 
  DHMD 2095 
p23 co-chaperone Q15185 DGAD 145 
  PEVD 142 
p65 Q04206 DCRD 97 
PTEN P60484 DVSD 371 
  NEPD 375 
  QEID 301 
Rad9 Q6FI29  DDID 304 
SCL/Tal-1 P17542 EITD 180 
    
 
1 Cleavage sites are reported as tetrapeptides in the order: P4-P3-P2-P1. Except for VQPE (from DIAP1), all cleavage 
sites have an Asp (D) in the P1 position.  
2 Indicates the position of the P1 amino acid in the protein sequence as reported in Uniprot. 
 
 
